Outcomes of allogeneic hematopoietic stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma. Reviewed International journal

Kato K, Sugio T, Ikeda T, Yoshitsugu K, Miyazaki K, Suzumiya J, Yamamoto G, Kim SW, Ikegame K, Uehara Y, Mori Y, Ishikawa J, Hiramoto N, Eto T, Nakazawa H, Kobayashi H, Serizawa K, Onizuka M, Fukuda T, Atsuta Y, Suzuki R.

Bone Marrow Transplant.   59 ( 3 )   306 - 314   2024.3

End-of-treatment 18[F]-FDG PET can predict early progression in patients receiving bendamustine-rituximab for follicular lymphoma in first relapse: a prospective West Japan hematology Study Group (W-JHS) NHL01 trial. Reviewed International journal

Kato K, Izutsu K, Nishikori M, Shibayama H, Maeda Y, Yoshimura K, Tateishi U, Miyamoto T, Matsuda Y, Ishikawa J, Rai S, Takahashi T, Yamauchi T, Matsumura I, Akashi K, Kanakura Y, Suzumiya J.

Int J Hematol.   2024.3

Impact of center volume on chronic graft versus host disease in patients with allogeneic stem cell transplantation. Reviewed International journal

Shimomura Y, Kitamura T, Murata M, Matsuo K, Ito Y, Ichinohe T, Hashii Y, Goto H, Kato K, Ishimaru F, Sato A, Onizuka M, Yanagisawa A, Ohbiki M, Tabuchi K, Atsuta Y, Fukuda T, Kanda J, Terakura S.

Transplant Cell Ther.   30 ( 3 )   326.e1 - 326.e14   2024.3

Tumor heterogeneity and immune-evasive T follicular cell lymphoma phenotypes at single-cell resolution. Reviewed International journal

Suma S, Suehara Y, Fujisawa M, Abe Y, Hattori K, Makishima K, Sakamoto T, Sawa A, Bando H, Kaji D, Sugio T, Kato K, Akashi K, Matsue K, Carreras J, Nakamura N, Suzuki A, Suzuki Y, Ito K, Shiiba H, Chiba S, Sakata-Yanagimoto M.

Leukemia.   38 ( 2 )   340 - 350   2024.2

Co-expression of regulatory B-cell markers, transforming growth factor β and interleukin-10 as a prognostic factor in diffuse large B-cell lymphoma. Reviewed International journal

254   155117   2024.2

Clinicopathological comparison between PTCL-TBX21 and PTCL-GATA3 in Japanese patients. Reviewed International journal

Shimasaki Y, Miyoshi H, Kawamoto K, Yoshida N, Mishina T, Nakashima K, Imamoto T, Sugio T, Yanagida E, Kato T, Yamada K, Takeuchi M, Suzuki T, Moritsubo M, Furuta T, Imaizumi Y, Takizawa J, Kato K, Suzumiya J, Suzuki R, Ohshima K.

Cancer Med.   13 ( 3 )   e6793   2024.2

Thrombospondin-1 is an endogenous substrate of cereblon responsible for immunomodulatory drugs-induced thromboembolism. Reviewed International journal

Hatakeyama K, Kikushige Y, Ishihara D, Yamamoto S, Kawano G, Tochigi T, Miyamoto T, Sakoda T, Christoforou A, Kunisaki Y, Fukata M, Kato K, Ito T, Handa H, Akashi K.

Blood Adv.   8 ( 3 )   785 - 796   2024.2

Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphoma. Reviewed International journal

Goto H, Ito S, Kizaki M, Yamaguchi M, Fukuhara N, Kato K, Saito T, Terui Y, Okubo S, Soshin T, Zeng J, Honda H, Badawi M, Ross JA, Izutsu K.

Int J Clin Oncol.   29 ( 2 )   232 - 240   2024.2

Myelodysplasia after clonal hematopoiesis with APOBEC3-mediated CYBB inactivation in retroviral gene therapy for X-CGD. Reviewed International journal

Uchiyama T, Kawai T, Nakabayashi K, Nakazawa Y, Goto F, Okamura K, Nishimura T, Kato K, Watanabe N, Miura A, Yasuda T, Ando Y, Minegishi T, Edasawa K, Shimura M, Akiba Y, Sato-Otsubo A, Mizukami T, Kato M, Akashi K, Nunoi H, Onodera M.

Mol Ther.   31 ( 12 )   3424 - 3440   2023.12

Safety and Efficacy of NY-ESO-1 Antigen-specific T-cell Receptor Gene-Transduced T Lymphocytes in Patients with Synovial Sarcoma: A Phase I/II Clinical Trial. Reviewed International journal

Kawai A, Ishihara M, Nakamura T, Kitano S, Iwata S, Takada K, Emori M, Kato K, Endo M, Matsumoto Y, Kakunaga S, Sato E, Miyahara Y, Morino K, Tanaka S, Takahashi S, Matsuo F, Matsumine A, Kageyama S, Ueda T.

Clin Cancer Res.   29 ( 24 )   5069 - 5078   2023.12

Measurable residual disease in Japanese patients with relapsed or refractory chronic lymphocytic leukemia treated with venetoclax. Reviewed International journal

Izutsu K, Yamamoto K, Kato K, Ishikawa T, Fukuhara N, Terui Y, Choi I, Okubo S, Ogawa N, Sakai M, Nishimura Y, Chyla B, Sun Y, Maruyama D.

Int J Hematol.   118 ( 4 )   526 - 528   2023.10

Improvement of Medication Guidance Sheet for Total Body Irradiation/Cyclophosphamide Followed by Allogeneic Hematopoietic Stem Cell Transplantation Based on Real Monitoring Data. Reviewed International journal

Uchida M, Ishida S, Mochizuki E, Ozawa N, Yonemitsu H, Ochiai H, Nakamura H, Kawashiri T, Kato K, Egashira N, Akashi K, Ieiri I.

Anticancer Res.   43 ( 9 )   4067 - 4075   2023.9

Development of Real-world Data-based Medication Instruction Sheet for Acute Myeloid Leukemia Patients Receiving High-dose Cytarabine Consolidation Therapy. Reviewed International journal

Uchida M, Ishida S, Mochizuki E, Ozawa N, Yonemitsu H, Ochiai H, Nakamura H, Kawashiri T, Kato K, Egashira N, Akashi K, Ieiri I.

Anticancer Res.   43   3321 - 3329   2023.7

Breakthrough candidemia with hematological disease: Results from a single-center retrospective study in Japan, 2009-2020. Reviewed International journal

Nishida R, Eriguchi Y, Miyake N, Nagasaki Y, Yonekawa A, Mori Y, Kato K, Akashi K, Shimono N.

Med Mycol.   2023.6

Impact of HLA-mismatched unrelated transplantation in patients with adult T-cell leukemia/lymphoma. Reviewed International journal

Inoue Y, Morishima S, Kato K, Ito A, Nakano N, Kuriyama T, Kawakita T, Mori Y, Suehiro Y, Itonaga H, Miyazaki Y, Imada K, Tomori S, Kanda J, Ichinohe T, Atsuta Y, Fukuda T, Yoshimitsu M; ATL Working Group of the Japanese Society for Transplantation and Cellular Therapy.

Bone Marrow Transplant.   2023.5

GPAM mediated lysophosphatidic acid synthesis regulates mitochondrial dynamics in acute myeloid leukemia. Reviewed International journal

Irifune H, Kochi Y, Miyamoto T, Sakoda T, Kato K, Kunisaki Y, Akashi K, Kikushige Y.

Cancer Sci.   2023.5

Cord blood is a suitable donor source of allogeneic hematopoietic cell transplantation for adult T-cell leukemia-lymphoma: a nationwide retrospective study. Reviewed International journal

Tokunaga M, Nakano N, Fuji S, Wake A, Utsunomiya A, Ito A, Eto T, Kawakita T, Mori Y, Moriuchi Y, Suehiro Y, Miyazaki Y, Uchida N, Sawayama Y, Ishitsuka K, Kanda J, Kimura T, Ichinohe T, Atsuta Y, Fukuda T, Yoshimitsu M, Kato K.

Bone Marrow Transplant.   58   462 - 464   2023.2

Panuveitis induced by donor-derived CD8+ T cells after allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia. Reviewed International journal

Takeda A, Sakoda T, Yawata N, Kato K, Hasegawa E, Shima T, Hikita S, Yoshitomi K, Takenaka K, Oda Y, Akashi K, Sonoda K.

American Journal of Ophthalmology Case Reports   2023.2

Case Report: Cardiac Tamponade in Association With Cytokine Release Syndrome Following CAR-T Cell Therapy. Reviewed International journal

Moriyama S, Fukata M, Yokoyama T, Ueno S, Nunomura T, Mori Y, Kato K, Miyamoto T, Akashi K.

Front Cardiovasc Med.   9   848091   2023.2

Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma. Reviewed International journal

Kameda T, Kataoka K, Kamiunten A, Hidaka M, Miyoshi H, Nakano N, Nosaka K, Yoshimitsu M, Yasunaga JI, Kogure Y, Shide K, Miyahara M, Sakamoto T, Akizuki K, Hidaka T, Kubuki Y, Koya J, Kawano N, Yamashita K, Kawano H, Toyama T, Maeda K, Marutsuka K, Imaizumi Y, Kato K, Sugio T, Tokunaga M, Tashiro Y, Takaori-Kondo A, Miyazaki Y, Akashi K, Ishitsuka K, Matsuoka M, Ohshima K, Watanabe T, Kitanaka A, Utsunomiya A, Ogawa S, Shimoda K.

Haematologica   2023.2

Five-year follow-up of a phase II study of DA-EPOCH-R with high-dose MTX in CD5-positive DLBCL. Reviewed International journal

Miyazaki K, Sakai R, Iwaki N, Yamamoto G, Murayama K, Nishikori M, Sunami K, Yoshida I, Yano H, Takahashi N, Okamoto A, Munemoto S, Sawazaki A, Suehiro Y, Fukuhara N, Wake A, Arai A, Masaki Y, Toyama K, Yokoyama A, Tsunemine H, Hasegawa Y, Matsumoto K, Yamada T, Nishimura Y, Tamaru S, Asano N, Miyawaki K, Izutsu K, Kinoshita T, Suzuki R, Ohshima K, Kato K, Katayama N, Yamaguchi M.

Cancer Sci.   114   2689 - 2691   2023.2

Usefulness of a Medication Instruction Sheet for Patients Receiving Cytarabine and Idarubicin Induction Therapy for Acute Myeloid Leukemia. Reviewed International journal

Uchida M, Mochizuki E, Ishida S, Ozawa N, Yonemitsu H, Ochiai H, Nakamura H, Kawashiri T, Kato K, Egashira N, Akashi K, Ieiri I.

In Vivo.   37   924 - 932   2023.2

Safety and efficacy of tisagenlecleucel in patients with relapsed or refractory B-cell lymphoma: the first real-world evidence in Japan. Reviewed International journal

Goto H, Kitawaki T, Fujii N, Kato K, Onishi Y, Fukuhara N, Yamauchi T, Toratani K, Kobayashi H, Yoshida S, Shimo M, Onodera K, Senjo H, Onozawa M, Hirata K, Yokota I, Teshima T.

Int J Clin Oncol.   28   816 - 826   2023.2

TIM-3 signaling hijacks the canonical Wnt/β-catenin pathway to maintain cancer stemness in acute myeloid leukemia. Reviewed International journal

7   2053 - 2065   2023.2

Population pharmacokinetic model and dosing optimization of vancomycin in hematologic malignancies with neutropenia and augmented renal clearance. Reviewed International journal

Belabbas T, Yamada T, Egashira N, Hirota T, Suetsugu K, Mori Y, Kato K, Akashi K, Ieiri I.

J Infect Chemother.   29   391 - 400   2023.2

Pseudo-progressive bone lesion in an infant leukemia after chimeric antigen receptor-T cell therapy. Reviewed International journal

Yokoyama S, Koga Y, Anan T, Kato K, Ohga S.

Pediatr Int.   65   e15399   2023.1

A phase 2 study of axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma in Japan: 1-year follow-up and biomarker analysis. Reviewed International journal

Kato K, Fujii N, Makita S, Goto H, Kanda J, Shimada K, Akashi K, Izutsu K, Teshima T, Fukuda N, Sumitani T, Nakamura S, Sumi H, Shimizu S, Kakurai Y, Yoshikawa K, Tobinai K, Usui N, Hatake K.

Int J Hematol.   117   409 - 420   2023.1

Chimeric antigen receptor T-cell therapy targeting a MAGE A4 peptide and HLA-A*02:01 complex for unresectable advanced or recurrent solid cancer: protocol for a multi-institutional phase 1 clinical trial. Reviewed International journal

Okumura S, Ishihara M, Kiyota N, Yakushijin K, Takada K, Kobayashi S, Ikeda H, Endo M, Kato K, Kitano S, Matsumine A, Nagata Y, Kageyama S, Shiraishi T, Yamada T, Horibe K, Takesako K, Miwa H, Watanabe T, Miyahara Y, Shiku H.

BMJ Open.   12   e065109   2023.1

Comparison of transplant outcomes between haploidentical transplantation and single cord blood transplantation in non-remission acute myeloid leukaemia: A nationwide retrospective study. Reviewed International journal

Matsuda K, Konuma T, Fuse K, Masuko M, Kawamura K, Hirayama M, Uchida N, Ikegame K, Wake A, Eto T, Doki N, Miyakoshi S, Tanaka M, Takahashi S, Onizuka M, Kato K, Kimura T, Ichinohe T, Takayama N, Kobayashi H, Nakamae H, Atsuta Y, Kanda J, Yanada M.

Br J Haematol.   201   106 - 113   2023.1

Efficacy and safety of tisagenlecleucel in adult Japanese patients with relapsed or refractory follicular lymphoma: results from the phase 2 ELARA trial. Reviewed International journal

Fukuhara N, Kato K, Goto H, Takeshi T, Kawaguchi M, Tokushige K, Akashi K, Teshima T, Harigae H, Schuster SJ, Thieblemont C, Dreyling M, Fowler N.

Int J Hematol.   117   251 - 259   2023.1

Clinical Pharmacology and Determinants of Response to UCART19, an Allogeneic Anti-CD19 CAR-T Cell Product, in Adult B-cell Acute Lymphoblastic Leukemia. Reviewed International journal

Dupouy S, Marchiq I, Derippe T, Almena-Carrasco M, Jozwik A, Fouliard S, Adimy Y, Geronimi J, Graham C, Jain N, Maus MV, Mohamad M, Boissel N, Teshima T, Kato K, Benjamin R, Balandraud S.

Cancer Research Communications.   2   1520 - 1531   2022.12

Successful pseudo-autologous stem cell transplantation for donor-derived Burkitt lymphoma occurring 9 years after allogeneic transplantation. Reviewed International journal

Taniguchi S, Utsumi S, Kochi Y, Taya Y, Mori Y, Semba YI, Sugio T, Miyawaki K, Kikushige Y, Kunisaki Y, Yoshimoto G, Numata A, Kato K, Uchida N, Maeda T, Miyamoto T, Taniguchi S, Akashi K.

Int J Hematol.   2022.9

UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial. Reviewed International journal

Benjamin R, Jain N, Maus MV, Boissel N, Graham C, Jozwik A, Yallop D, Konopleva M, Frigault MJ, Teshima T, Kato K, Boucaud F, Balandraud S, Gianella-Borradori A, Binlich F, Marchiq I, Dupouy S, Almena-Carrasco M, Pannaux M, Fouliard S, Brissot E, Mohty M; CALM Study Group.

Lancet Haematol.   9   e833 - e843   2022.9

Human acute leukemia utilizes branched-chain amino acid catabolism to maintain stemness through regulating PRC2 function. Reviewed International journal

Kikushige Y, Miyamoto T, Kochi Y, Semba Y, Ohishi M, Irifune H, Hatakeyama K, Kunisaki Y, Sugio T, Sakoda T, Miyawaki K, Kato K, Soga T, Akashi K.

Blood Adv.   2022.8

Improved survival after single-unit cord blood transplantation using fludarabine and melphalan-based reduced-intensity conditioning for malignant lymphoma: impact of melphalan dose and graft-versus-host disease prophylaxis with mycophenolate mofetil. Reviewed International journal

Sakatoku K, Kim SW, Okamura H, Kanaya M, Kato K, Yamasaki S, Uchida N, Kobayashi H, Fukuda T, Takayama N, Ishikawa J, Nakazawa H, Sakurai M, Ikeda T, Kondo T, Yoshioka S, Miyamoto T, Kimura T, Ichinohe T, Atsuta Y, Kondo E.

Ann Hematol.   101   2743 - 2757   2022.8

Zandelisib (ME-401) in Japanese patients with relapsed or refractory indolent non-Hodgkin's lymphoma: an open-label, multicenter, dose-escalation phase 1 study. Reviewed International journal

Goto H, Izutsu K, Ennishi D, Mishima Y, Makita S, Kato K, Hanaya M, Hirano S, Narushima K, Teshima T, Nagai H, Ishizawa K.

Int J Hematol   116   911 - 921   2022.8

Rapid decrease in eGFR with concomitant use of tyrosine kinase inhibitors and renin-aldosterone-angiotensin system inhibitors in patients with chronic myelogenous leukemia. Reviewed International journal

Tsuda M, Hirata A, Tokunaga S, Masuda T, Haji S, Kimura D, Nojiri C, Nakashima Y, Shiratsuchi M, Kato K, Miyamoto T, Akashi K, Nakashima N, Ogawa Y

Int J Hematol   116 ( 6 )   863 - 870   2022.8

Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma Reviewed International journal

N Engl J Med.   386 ( 26 )   2482 - 2494   2022.7

Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma. Reviewed International journal

Jaeger U, Tam CS, Borchmann P, McGuirk JP, Johansen M, Waller EK, Jaglowski SM, Andreadis C, Foley RR, Westin JR, Fleury I, Ho PJ, Mielke S, Teshima T, Salles GA, Schuster SJ, He FC, Maziarz RT, Mayer SA, Makita S, Kersten MJ, Ghosh M, Wagner-Johnston ND, Kato K, Corradini P, Goto H, Colicino S, Agarwal A, Lobetti-Bodoni CL, Bishop MR.

Blood Adv.   6   4816 - 4820   2022.7

Oral histone deacetylase inhibitor tucidinostat (HBI-8000) in patients with relapsed or refractory adult T-cell leukemia/lymphoma: Phase IIb results Reviewed International journal

Utsunomiya A, Izutsu K, Jo T, Yoshida S, Tsukasaki K, Ando K, Choi I, Imaizumi Y, Kato K, Kurosawa M, Kusumoto S, Miyagi T, Ohtsuka E, Sasaki O, Shibayama H, Shimoda K, Takamatsu Y, Takano K, Yonekura K, Makita S, Taguchi J, Gillings M, Onogi H, Tobinai K.

CANCER SCIENCE   2022.6

Prognostic value of pre-transplantation total metabolic tumor volume on 18fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography in relapsed and refractory aggressive lymphoma. Reviewed International journal

Sugio T, Baba S, Mori Y, Yoshimoto G, Kamesaki K, Takashima S, Urata S, Shima T, Miyawaki K, Kikushige Y, Kunisaki Y, Numata A, Takenaka K, Iawasaki H, Miyamoto T, Ishigami K, Akashi K, Kato K.

Int J Hematol.   116   603 - 611   2022.5

Risk factors for late cytomegalovirus infection after completing letermovir prophylaxis Reviewed International journal

Mori Y, Harada T, Yoshimoto G, Shima T, Numata A, Jinnouchi F, Yamauchi T, Kikushige Y, Kunisaki Y, Kato K, Takenaka K, Akashi K, Miyamoto T.

INTERNATIONAL JOURNAL OF HEMATOLOGY   2022.5

Usefulness of Medication Guidance Sheets for Patients With Non-Hodgkin's Lymphoma Receiving ESHAP±R Therapy. Reviewed International journal

42 ( 4 )   2053 - 2060   2022.4

A Germinal Center-Associated Microenvironmental Signature Reflects Malignant Phenotype and Outcome of DLBCL. Reviewed International journal

Miyawaki K, Kato K, Sugio T, Sasaki K, Miyoshi H, Semba Y, Kikushige Y, Mori Y, Kunisaki Y, Iwasaki H, Miyamoto T, Kuo FC, Aster JC, Ohshima K, Maeda T, Akashi K.

Blood Adv.   6 ( 7 )   2388 - 2402   2022.4

TET2 Clonal Hematopoiesis Is Associated With Anthracycline-Induced Cardiotoxicity in Patients With Lymphoma Reviewed International journal

Hatakeyama K, Hieda M, Semba Y, Moriyama S, Wang Y, Maeda T, Kato K, Miyamoto T, Akashi K, Kikushige Y.

JACC: CARDIOONCOLOGY   4 ( 1 )   141 - 143   2022.3

Case Report: Cardiac Tamponade in Association With Cytokine Release Syndrome Following CAR-T Cell Therapy. Reviewed International journal

Moriyama S, Fukata M, Yokoyama T, Ueno S, Nunomura T, Mori Y, Kato K, Miyamoto T, Akashi K.

Front Cardiovasc Med.   9   848091   2022.3

Impact of donor types on reduced-intensity conditioning allogeneic stem cell transplant for mature lymphoid malignancies Reviewed International journal

Imahashi N, Terakura S, Kondo E, Kato K, Kim SW, Shinohara A, Watanabe M, Fukuda T, Uchida N, Kobayashi H, Ishikawa J, Kataoka K, Shiratori S, Ikeda T, Matsuoka KI, Yoshida S, Kondo T, Kimura T, Onizuka M, Ichinohe T, Atsuta Y, Kanda J.

BONE MARROW TRANSPLANTATION   57 ( 2 )   243 - 251   2022.2

Lymphoid and myeloid proliferative disorders associated with inflammatory bowel disease: a clinicopathological study of 15 cases Reviewed International journal

Hori Y, Yamamoto H, Kawatoko S, Nozaki Y, Torisu T, Kato K, Koga Y, Miyoshi H, Ohshima K, Tateishi Y, Nakamura S, Kitazono T, Oda Y.

HUMAN PATHOLOGY   120   88 - 98   2022.2

Long-term follow-up of patients with ATL after autologous stem cell transplantation Reviewed International journal

Utsunomiya A, Tokunaga M, Nakano N, Fujiwara H, Miyamoto T, Ogata M, Miyazaki Y, Ishitsuka K, Sakaida E, Taji H, Wakayama T, Ichinohe T, Fukuda T, Atsuta Y, Kato K, Yoshimitsu M.

BONE MARROW TRANSPLANTATION   57 ( 2 )   323 - 325   2022.2

Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial Reviewed International journal

NATURE MEDICINE   28 ( 2 )   325 - 332   2022.2

Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma Reviewed International journal

NEW ENGLAND JOURNAL OF MEDICINE   386 ( 7 )   629 - 639   2022.2

Phase 2 study of axicabtagene ciloleucel in Japanese patients with relapsed or refractory large B-cell lymphoma Reviewed International journal

Kato K, Makita S, Goto H, Kanda J, Fujii N, Shimada K, Akashi K, Izutsu K, Teshima T, Fukuda N, Sumitani T, Sumi H, Shimizu S, Kakurai Y, Yoshikawa K, Tobinai K, Usui N, Hatake K.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY   27 ( 1 )   213 - 223   2022.1

Short-term methotrexate plus cyclosporine for graft-versus-host disease prophylaxis after single-unit cord blood transplantation following reduced-intensity conditioning. Reviewed

Sugio T, Kato K, Yoshida S, Saito N, Kawano I, Henzan H, Miyamoto T, Akashi K, Eto T.

Japanese Journal of Transplantation and Cellular Therapy   11 ( 1 )   64 - 71   2022.1

Incidence of refractory cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation Reviewed International journal

Jinnouchi F, Mori Y, Yoshimoto G, Yamauchi T, Nunomura T, Yurino A, Hayashi M, Yuda J, Shima T, Odawara J, Takashima S, Kamezaki K, Kato K, Miyamoto T, Akashi K, Takenaka K.

INTERNATIONAL JOURNAL OF HEMATOLOGY   115 ( 1 )   96 - 106   2022.1

Impact of conditioning intensity and regimen on transplant outcomes in patients with adult T-cell leukemia-lymphoma Reviewed International journal

Inoue Y, Nakano N, Fuji S, Eto T, Kawakita T, Suehiro Y, Miyamoto T, Sawayama Y, Uchida N, Kondo T, Kanda J, Atsuta Y, Fukuda T, Yoshimitsu M, Kato K.

BONE MARROW TRANSPLANTATION   56 ( 12 )   2964 - 2974   2021.12

Autopsy of a patient with fatal Epstein-Barr virus-associated encephalitis after treatment with immune checkpoint inhibitors for advanced lung adenocarcinoma: A case report. Reviewed International journal

Ishioka K, Oki K, Hirose S, Oguri T, Sasada S, Murata S, Tsuchiya Y, Shigematsu L, Narita H, Adachi T, Fuji Y, Nakamura M, Kitano S, Kato K, Ohshima K, Takahashi S.

Current Problems in Cancer   4   100108   2021.12

Optimization of lymphapheresis for manufacturing autologous CAR-T cells Reviewed International journal

Yamanaka I, Yamauchi T, Henzan T, Sakoda T, Miyamoto K, Mishima H, Ono H, Koga Y, Nakashima Y, Kato K, Miyamoto T, Mizuno S, Ogawa Y, Ohga S, Akashi K, Maeda T, Kunisaki Y.

Int J Hematol   114 ( 4 )   449 - 458   2021.10

Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study Reviewed International journal

Schuster SJ, Tam CS, Borchmann P, Worel N, McGuirk JP, Holte H, Waller EK, Jaglowski S, Bishop MR, Damon LE, Foley SR, Westin JR, Fleury I, Ho PJ, Mielke S, Teshima T, Janakiram M, Hsu JM, Izutsu K, Kersten MJ, Ghosh M, Wagner-Johnston N, Kato K, Corradini P, Martinez-Prieto M, Han X, Tiwari R, Salles G, Maziarz RT.

LANCET ONCOLOGY   22 ( 10 )   1403 - 1415   2021.10

Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational study Reviewed International journal

Ito A, Nakano N, Tanaka T, Fuji S, Makiyama J, Inoue Y, Choi I, Nakamae H, Nagafuji K, Takase K, Machida S, Takahashi T, Sawayama Y, Kamimura T, Kato K, Kawakita T, Ogata M, Sakai R, Shiratori S, Uchimaru K, Inamoto Y, Utsunomiya A, Fukuda T.

BLOOD ADVANCES   5 ( 20 )   4156 - 4166   2021.10

Azacitidine for the treatment of patients with relapsed acute myeloid leukemia after allogeneic stem cell transplantation Reviewed International journal

Yoshimoto G, Mori Y, Kato K, Odawara J, Kuriyama T, Ueno T, Obara T, Yurino A, Yoshida S, Ogawa R, Ohno Y, Iwasaki H, Eto T, Akashi K, Miyamoto T.

LEUKEMIA & LYMPHOMA   62 ( 12 )   2939 - 2948   2021.10

Outcomes of methotrexate-associated lymphoproliferative disorders in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs Reviewed International journal

Harada T, Iwasaki H, Muta T, Urata S, Sakamoto A, Kohno K, Takase K, Miyamura T, Sawabe T, Asaoku H, Oryoji K, Fujisaki T, Mori Y, Yoshimoto G, Ayano M, Mitoma H, Miyamoto T, Niiro H, Yamamoto H, Oshiro Y, Miyoshi H, Ohshima K, Takeshita M, Akashi K, Kato K.

British journal of haematology   194 ( 1 )   101 - 110   2021.7

Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease Reviewed International journal

Zeiser R, Polverelli N, Ram R, Hashmi SK, Chakraverty R, Middeke JM, Musso M, Giebel S, Uzay A, Langmuir P, Hollaender N, Gowda M, Stefanelli T, Lee SJ, Teshima T, Locatelli F; REACH3 Investigators (Collaborators of Japan: Kato K et al).

NEW ENGLAND JOURNAL OF MEDICINE   385 ( 3 )   228 - 238   2021.7

A phase I/II multicenter trial of HLA-haploidentical PBSCT with PTCY for aggressive adult T-cell leukemia/lymphoma. Reviewed International journal

Tanaka T, Nakamae H, Ito A, Fuji S, Hirose A, Eto T, Henzan H, Takase K, Yamasaki S, Makiyama J, Moriuchi Y, Choi I, Nakano N, Hiramoto N, Kato K, Sato T, Sawayama Y, Kim SW, Inoue Y, Inamoto Y, Fukuda T.

Transplant Cell Ther.   27 ( 11 )   928.e1 - 928.e7   2021.6

Safety and antitumor activity of acalabrutinib for relapsed/refractory B-cell malignancies: A Japanese phase I study Reviewed International journal

Izutsu K, Ando K, Ennishi D, Shibayama H, Suzumiya J, Yamamoto K, Ichikawa S, Kato K, Kumagai K, Patel P, Iizumi S, Hayashi N, Kawasumi H, Murayama K, Nagai H.

CANCER SCIENCE   2021.5

ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma. Reviewed International journal

J Clin Oncol.   39   1317 - 1328   2021.5

A phase 2 study of polatuzumab vedotin + bendamustine + rituximab in relapsed/refractory diffuse large B-cell lymphoma. Reviewed International journal

Terui Y, Rai S, Izutsu K, Yamaguchi M, Takizawa J, Kuroda J, Ishikawa T, Kato K, Suehiro Y, Fukuhara N, Ohmine K, Goto H, Yamamoto K, Kanemura N, Ueda Y, Ishizawa K, Kumagai K, Kawasaki A, Saito T, Hashizume M, Shibayama H.

Cancer Sci.   112   2845 - 2854   2021.5

Phase 2 study of E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T-cell lymphoma. Reviewed International journal

Kawai H, Ando K, Maruyama D, Yamamoto K, Kiyohara E, Terui Y, Fukuhara N, Miyagaki T, Tokura Y, Sakata-Yanagimoto M, Igarashi T, Kuroda J, Fujita J, Uchida T, Ishikawa T, Yonekura K, Kato K, Nakanishi T, Nakai K, Matsunaga R, Tobinai K.

Cancer Sci.   2021.5

Efficacy of prophylactic letermovir for cytomegalovirus reactivation in hematopoietic cell transplantation: a multicenter real-world data. Reviewed International journal

Mori Y, Jinnouchi F, Takenaka K, Aoki T, Kuriyama T, Kadowaki M, Odawara J, Ueno T, Kohno K, Harada T, Yoshimoto G, Takase K, Henzan H, Kato K, Ito Y, Kamimura T, Ohno Y, Ogawa R, Eto T, Nagafuji K, Akashi K, Miyamoto T.

BONE MARROW TRANSPLANTATION   56   853 - 862   2021.4

Phase 1/2 study of venetoclax, a BCL-2 inhibitor, in Japanese patients with relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma Reviewed International journal

Izutsu K, Yamamoto K, Kato K, Ishikawa T, Fukuhara N, Terui Y, Choi I, Humphrey K, Kim SY, Okubo S, Ogawa N, Nishimura Y, Salem AH, Maruyama D.

INTERNATIONAL JOURNAL OF HEMATOLOGY   113 ( 3 )   370 - 380   2021.3

GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma Reviewed International journal

Muranushi H, Shindo T, Hishizawa M, Tokunaga M, Wake A, Nakano N, Eto T, Hidaka M, Choi I, Miyamoto T, Uchida N, Moriuchi Y, Miyazaki Y, Fukuda T, Ichinohe T, Atsuta Y, Kato K.

BONE MARROW TRANSPLANTATION   56 ( 1 )   155 - 166   2021.1

Outcome of allogeneic hematopoietic stem cell transplantation for follicular lymphoma relapsing after autologous transplantation: analysis of the Japan Society for Hematopoietic Cell Transplantation Reviewed International journal

Sakurai, Masatoshi; Mori, Takehiko; Kato, Koji; Kanaya, Minoru; Mizuno, Shohei; Shiratori, Souichi; Wakayama, Toshio; Uchida, Naoyuki; Kobayashi, Hikaru; Kubo, Kohmei; Amano, Itsuto; Ohta, Takanori; Miyazaki, Yasuhiko; Kanda, Junya; Fukuda, Takahiro; Atsuta, Yoshiko; Kondo, Eisei

BONE MARROW TRANSPLANTATION   2021.1

Chromosomal defects and survival in patients with adult T-cell leukemia/lymphoma after allogeneic HSCT Invited Reviewed International journal

Nakano, Nobuaki; Utsunomiya, Atae; Matsuo, Keitaro; Yoshida, Noriaki; Seto, Masao; Ohshima, Kouichi; Fujiwara, Hiroshi; Fuji, Shigeo; Takatsuka, Yoshifusa; Ito, Ayumu; Miyamoto, Toshihiro; Suehiro, Youko; Nakamae, Hirohisa; Sawayama, Yasushi; Yuasa, Mitsuhiro; Miyazaki, Yasuhiko; Ota, Shuichi; Imada, Kazunori; Fukuda, Takahiro; Ichinohe, Tatsuo; Atsuta, Yoshiko; Kato, Koji

BLOOD ADVANCES   5 ( 2 )   475 - 486   2021.1

Outcome predictors after retransplantation in relapsed acute lymphoblastic leukemia: a multicenter, retrospective study Reviewed International journal

Mori, Yasuo; Sasaki, Kensuke; Ito, Yoshikiyo; Kuriyama, Takuro; Ueno, Toshiyuki; Kadowaki, Masanori; Aoki, Takatoshi; Sugio, Takeshi; Yoshimoto, Goichi; Kato, Koji; Maeda, Takahiro; Nagafuji, Koji; Akashi, Koichi; Miyamoto, Toshihiro

ANNALS OF HEMATOLOGY   100 ( 1 )   197 - 208   2021.1

B cell receptor signaling related to resistance to Helicobacter pylori eradication therapy in gastric diffuse large B cell lymphoma. Reviewed International journal

Takehiro Torisu, Shinichi Kawano, Kohta Miyawaki, Hidetaka Yamamoto, Yutaro Ihara, Yuichi Matsuno, Kumiko Torisu, Takeshi Sugio, Kensuke Sasaki, Takashi Shimakawa, Koji Kato, Koichi Akashi, Shotaro Nakamura, Takanari Kitazono

Hematological oncology   2020.10

Plasmablastic lymphoma occurring in the vicinity of enterocutaneous fistula in Crohn's disease. Invited Reviewed International journal

Seisho Sato, Makiko Nakahara, Koji Kato, Tomohiko Moriyama, Sae Utsumi, Kensuke Sasaki, Takahiro Shima, Hiroaki Miyoshi, Hidetaka Yamamoto, Masutaka Furue

The Journal of dermatology   2020.9

HTLV-1 seropositive patients with lung cancer treated with PD-1 inhibitors Reviewed International journal

Yoneshima Y*, Kato K*, Minami H, Ikeda M, Watanabe H, Yoshimoto G, Miyamoto T, Akashi K, Nakanishi Y, Okamoto I. (*Equal contribution to this work)

Cancer Sci.   2020.7

Phase I study of duvelisib in Japanese patients with relapsed or refractory lymphoma. Reviewed International journal

Izutsu K, Kato K, Kiyoi H, Yamamoto G, Shimada K, Akashi K.

Int J Hematol.   2020.7

Measurable residual disease after the first consolidation predicts the outcomes of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Reviewed International journal

Henzan H, Takase K, Kamimura T, Mori Y, Yoshimoto G, Iwasaki H, Nagafuji K, Ogawa R, Eto T, Uchida N, Fujisaki T, Kato K, Minami M, Kikushige Y, Akashi K, Miyamoto T.

Int J Hematol.   2020.7

Efficacy and safety of tisagenlecleucel in Japanese adult patients with relapsed/refractory diffuse large B-cell lymphoma. Reviewed International journal

Goto H, Makita S, Kato K, Tokushige K, Fujita T, Akashi K, Izutsu K, Teshima T.

Int J Clin Oncol.   2020.7

Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease. Reviewed International journal

N Engl J Med.   2020.7

Combination of CD47 and SIRPα constituting the "don't eat me signal" is a prognostic factor in diffuse large B-cell lymphoma. Reviewed International journal

2020.7

TKIs induce alternative spliced BCR-ABL(Ins35bp) variant via inhibition of RNA polymerase Ⅱ on genomic BCR-ABL. Reviewed International journal

2020.7

Aromatase is a novel neo-substrate of cereblon responsible for immunomodulatory drugs-induced thrombocytopenia. Reviewed International journal

Tochigi T, Miyamoto T, Hatakeyama K, Sakoda T, Ishihara D, Irifune H, Shima T, Kato K, Maeda T, Ito T, Handa H, Akashi K, Kikushige Y.

Blood   2020.7

Establishment of a human SIRPA knock-in xenograft mouse model to study human hematopoietic and cancer stem cells. Reviewed International journal

Jinnouchi F, Yamauchi T, Yurino A, Nunomura T, Nakano M, Iwamoto C, Obara T, Miyawaki K, Kikushige Y, Kato K, Maeda T, Miyamoto T, Baba E, Akashi K, Takenaka K.

Blood   2020.7

DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase 2 study. Reviewed International journal

Miyazaki K, Asano N, Yamada T, Miyawaki K, Sakai R, Igarashi T, Nishikori M, Ohata K, Sunami K, Yoshida I, Yamamoto G, Takahashi N, Okamoto M, Yano H, Nishimura Y, Tamaru S, Nishikawa M, Izutsu K, Kinoshita T, Suzumiya J, Ohshima K, Kato K, Katayama N, Yamaguchi M.

Haematologica   2020.7

Successful allogeneic stem cell transplantation in a case with acute myeloid leukemia and invasive Schizophyllum commune rhinosinusitis Reviewed

Takuya Harada, Takuro Kuriyama, Ruriko Nishida, Goichi Yoshimoto, Yasuo Mori, Hiroshi Imanaga, Toshiyuki Ueno, Jun Odawara, Masayasu Hayashi, Koji Kato, Katsuto Takenaka, Koichi Akashi, Toshihiro Miyamoto

Journal of Infection and Chemotherapy   26 ( 5 )   506 - 509   2020.5

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for ATL with HTLV-1 Antibody-Positive Donors Allo-HCT for ATL from HTLV-1 Antibody-Positive Donors Reviewed

Makoto Yoshimitsu, Shigeo Fuji, Atae Utsunomiya, Nobuaki Nakano, Ayumu Ito, Yoshikiyo Ito, Toshihiro Miyamoto, Youko Suehiro, Toshiro Kawakita, Yukiyoshi Moriuchi, Hirohisa Nakamae, Yoshinobu Kanda, Tatsuo Ichinohe, Takahiro Fukuda, Yoshiko Atsuta, Koji Kato

Biology of Blood and Marrow Transplantation   26 ( 4 )   718 - 722   2020.4

Comparison of the outcomes after haploidentical and cord blood salvage transplantations for graft failure following allogeneic hematopoietic stem cell transplantation Reviewed

Kaito Harada, Shigeo Fuji, Sachiko Seo, Junya Kanda, Toshimitsu Ueki, Fumihiko Kimura, Koji Kato, Naoyuki Uchida, Kazuhiro Ikegame, Makoto Onizuka, Ken ichi Matsuoka, Noriko Doki, Toshiro Kawakita, Yasushi Onishi, Shingo Yano, Takahiro Fukuda, Minoko Takanashi, Yoshinobu Kanda, Yoshiko Atsuta, Masao Ogata, Kaito Harada, Shigeo Fuji, Sachiko Seo, Toshimitsu Ueki, Masao Ogata

Bone Marrow Transplantation   2020.1

Effects of stem cell transplantation in patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma Reviewed

Satoshi Yamasaki, Shuro Yoshida, Koji Kato, Ilseung Choi, Yutaka Imamura, Kentaro Kohno, Hideho Henzan, Kazuki Tanimoto, Ryosuke Ogawa, Youko Suehiro, Toshihiro Miyamoto, Tetsuya Eto, Koichi Ohshima, Koichi Akashi, Hiromi Iwasaki

International journal of hematology   2020.1

Cyclophosphamide-Induced Tolerance in Allogeneic Transplantation From Basic Studies to Clinical Application Reviewed

Koji Kato, Ario Takeuchi, Koichi Akashi, Masatoshi Eto

Frontiers in Immunology   10   2020.1

Successful outcome with reduced-intensity condition regimen followed by allogeneic hematopoietic stem cell transplantation for relapsed or refractory anaplastic large-cell lymphoma Reviewed

Reiji Fukano, Tetsuya Mori, Naoto Fujita, Ryoji Kobayashi, Tetsuo Mitsui, Koji Kato, Ritsuro Suzuki, Junji Suzumiya, Takahiro Fukuda, Motohiro Shindo, Nobuo Maseki, Tatsu Shimoyama, Keiko Okada, Masami Inoue, Jiro Inagaki, Yoshiko Hashii, Atsushi Sato, Ken Tabuchi

International journal of hematology   110 ( 6 )   723 - 728   2019.12

Clinical outcomes of hepatitis B or C virus infections in patients with malignant lymphoma receiving autologous stem cell transplantation on behalf of the Adult Lymphoma Working Group of the Japan Society for Haematopoietic Cell Transplantation (JSHCT) Reviewed

Harumi Kato, Koji Kato, Sung Won Kim, Takahiro Fukuda, Takehiko Mori, Masashi Sawa, Yuju Ohno, Satoshi Yoshioka, Yasuharu Iwato, Hirofumi Taji, Makoto Onizuka, Shingo Kurahashi, Tatsuo Ichinohe, Junji Suzumiya, Ritsuro Suzuki

British Journal of Haematology   186 ( 6 )   e170 - e175   2019.9

Safety and Seropositivity after Live Attenuated Vaccine in Adult Patients Receiving Hematopoietic Stem Cell Transplantation Reviewed

Takatoshi Aoki, Tomohiko Kamimura, Shuro Yoshida, Yasuo Mori, Masanori Kadowaki, Kentaro Kohno, Daisuke Ishihara, Shingo Urata, Takeshi Sugio, Kenjiro Kamezaki, Koji Kato, Yoshikiyo Ito, Tetsuya Eto, Koichi Akashi, Toshihiro Miyamoto

Biology of Blood and Marrow Transplantation   25 ( 8 )   1576 - 1585   2019.8

Methotrexate-associated Lymphoproliferative Disorders in Patients With Rheumatoid Arthritis Clinicopathologic Features and Prognostic Factors Reviewed

Daisuke Kurita, Hiroaki Miyoshi, Ayako Ichikawa, Koji Kato, Yoshitaka Imaizumi, Ritsuko Seki, Kensaku Sato, Yuya Sasaki, Keisuke Kawamoto, Joji Shimono, Kyohei Yamada, Reiji Muto, Masahiro Kizaki, Koji Nagafuji, Jun Ichi Tamaru, Michihide Tokuhira, Koichi Ohshima

American Journal of Surgical Pathology   43 ( 7 )   869 - 884   2019.7

Clinical effects of recombinant thrombomodulin and defibrotide on sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation Reviewed

Kimikazu Yakushijin, Takayuki Ikezoe, Chikako Ohwada, Kazuko Kudo, Hiroshi Okamura, Hiroaki Goto, Hiromasa Yabe, Atsushi Yasumoto, Hideyuki Kuwabara, Shiro Fujii, Kumiko Kagawa, Masao Ogata, Yasushi Onishi, Akio Kohno, Koichi Watamoto, Nobuhiko Uoshima, Daisuke Nakamura, Shuichi Ota, Yasunori Ueda, Tatsuo Oyake, Kazutoshi Koike, Ishikazu Mizuno, Hiroatsu Iida, Yoshio Katayama, Hiroatsu Ago, Koji Kato, Atsuo Okamura, Atsushi Kikuta, Takahiro Fukuda

Bone Marrow Transplantation   54 ( 5 )   674 - 680   2019.5

Cytomegalovirus reactivation is associated with increased mortality more than 100 days after allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma Reviewed

Yasushi Sawayama, Hidehiro Itonaga, Takuya Fukushima, Nobuaki Nakano, Hiroshi Fujiwara, Atae Utsunomiya, Takahiro Fukuda, Toshihiro Miyamoto, Tetsuya Eto, Kaname Miyashita, Hirohisa Nakamae, Masao Ogata, Atsushi Yamanoha, Yasuhiko Miyazaki, Junya Kanda, Yoshiko Atsuta, Koji Kato

American Journal of Hematology   94 ( 5 )   E143 - E146   2019.5

Clinicopathological features of HCV-positive splenic diffuse large B cell lymphoma Reviewed

Joji Shimono, Hiroaki Miyoshi, Fumiko Arakawa, Kyohei Yamada, Takeshi Sugio, Kohta Miyawaki, Tetsuya Eto, Takuto Miyagishima, Koji Kato, Koji Nagafuji, Koichi Akashi, Takanori Teshima, Koichi Ohshima

Annals of Hematology   98 ( 5 )   1197 - 1207   2019.5

The outcome and characteristics of patients with relapsed adult T cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation Reviewed

Koji Kato, Naokuni Uike, Atsushi Wake, Makoto Yoshimitsu, Tomomi Tobai, Yasushi Sawayama, Yoshifusa Takatsuka, Takahiro Fukuda, Naoyuki Uchida, Tetsuya Eto, Yasuhiro Nakashima, Tadakazu Kondo, Jun Taguchi, Toshihiro Miyamoto, Hirohisa Nakamae, Tatsuo Ichinohe, Koji Kato, Ritsuro Suzuki, Atae Utsunomiya

Hematological Oncology   37 ( 1 )   54 - 61   2019.2

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2) a global, double-blind, randomised, phase 3 trial Reviewed

The Lancet   393 ( 10168 )   229 - 240   2019.1

Usefulness of medication instruction sheets for sharing information on cancer chemotherapy within the health care team Reviewed

M. Uchida, T. Nakamura, H. Watanabe, K. Kato, T. Miyamoto, K. Akashi, S. Masuda

Pharmazie   74 ( 9 )   566 - 569   2019.1

The effectiveness of busulfan-based conditioning regimens for stem cell transplantation against lymphomas in children, adolescents, and young adults in Japan Reviewed

Daiki Hori, Ryoji Kobayashi, Naoto Fujita, Junji Suzumiya, Ritsuro Suzuki, Koji Kato, Takahito Kawata, Takahiro Fukuda, Masami Inoue, Hiroaki Goto, Asahito Hama, Koji Iwato, Hirokazu Okumura, Tetsuya Eto, Yoshiko Hashii, Yoshiko Atsuta, Tetsuo Mitsui

Pediatric Blood and Cancer   66 ( 10 )   2019.1

Previous exposure to bortezomib is linked to a lower risk of engraftment syndrome after autologous hematopoietic stem cell transplantation Reviewed

Yasuo Mori, Goichi Yoshimoto, Jun Ichiro Yuda, Masayasu Hayashi, Jun Odawara, Takuro Kuriyama, Takeshi Sugio, Kohta Miyawaki, Kenjiro Kamezaki, Koji Kato, Katsuto Takenaka, Hiromi Iwasaki, Takahiro Maeda, Toshihiro Miyamoto, Koichi Akashi

Leukemia and Lymphoma   60 ( 1 )   271 - 273   2019.1

Evaluation of the compliance with antiemetic guidelines for prevention of chemotherapy-induced nausea and vomiting in patients with hematologic malignancy Reviewed

M. Uchida, T. Nakamura, T. Shima, Y. Mori, G. Yoshimoto, K. Kato, M. Shimokawa, K. Hosohata, T. Miyamoto, K. Akashi

Pharmazie   74 ( 4 )   250 - 254   2019.1

Clinical practice recommendations for the diagnosis and management of human herpesvirus-6B encephalitis after allogeneic hematopoietic stem cell transplantation the Japan Society for Hematopoietic Cell Transplantation Reviewed

Masao Ogata, Naoyuki Uchida, Takahiro Fukuda, Kazuhiro Ikegame, Tomohiko Kamimura, Makoto Onizuka, Koji Kato, Hikaru Kobayashi, Yoji Sasahara, Masashi Sawa, Akihisa Sawada, Daiichiro Hasegawa, Masayoshi Masuko, Toshihiro Miyamoto, Shinichiro Okamoto

Bone Marrow Transplantation   2019.1

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma Invited Reviewed International journal

NEW ENGLAND JOURNAL OF MEDICINE   380 ( 1 )   45 - 56   2019.1

Successful rescue transplantation with desensitization procedure after primary graft failure due to donor-specific antibody Reviewed

Mariko Minami, Takumi Matsushima, Yasuo Mori, Daisuke Ishihara, Fumiaki Jinnnouchi, Katsuto Takenaka, Henzan Tomoko, Goichi Yoshimoto, Akihiko Numata, Koji Kato, Takahiro Maeda, Toshihiro Miyamoto, Koichi Akashi

Bone Marrow Transplantation   2019.1

Outcome of patients receiving consolidative autologous peripheral blood stem cell transplantation in the frontline treatment of intravascular large B-cell lymphoma Adult Lymphoma Working Group of the Japan Society for Hematopoietic Cell Transplantation Reviewed

Koji Kato, Takehiko Mori, Sung Won Kim, Masashi Sawa, Tomoyuki Sakai, Hisako Hashimoto, Jun Taguchi, Tatsuo Oyake, Shingo Kurahashi, Kazunori Imada, Hitoshi Ohno, Junji Tanaka, Tatsuo Ichinohe, Yoshiko Atsuta, Ritsuro Suzuki, Junji Suzumiya

Bone Marrow Transplantation   2019.1

Impact of pretransplant central nervous system invasion in patients with aggressive adult T-cell leukemia lymphoma Reviewed

Shigeo Fuji, Yoshitaka Inoue, Atae Utsunomiya, Yukiyoshi Moriuchi, Ilseung Choi, Eiichi Otsuka, Hideho Henzan, Koji Kato, Sawako Nakachi, Hisashi Yamamoto, Takahiro Fukuda

Bone Marrow Transplantation   54 ( 1 )   134 - 137   2019.1

Human Herpes Virus-6–Associated Encephalitis/Myelitis Mimicking Calcineurin Inhibitor–Induced Pain Syndrome in Allogeneic Stem Cell Transplantation Recipients Reviewed

24 ( 12 )   2540 - 2548   2018.12

Analysis of GNA13 Protein in Follicular Lymphoma and its Association with Poor Prognosis Reviewed

Joji Shimono, Hiroaki Miyoshi, Noriaki Yoshida, Takeharu Kato, Kensaku Sato, Takeshi Sugio, Kohta Miyawaki, Daisuke Kurita, Yuya Sasaki, Keisuke Kawamoto, Yoshitaka Imaizumi, Koji Kato, Koji Nagafuji, Koichi Akashi, Masao Seto, Takanori Teshima, Koichi Ohshima

American Journal of Surgical Pathology   42 ( 11 )   1466 - 1471   2018.11

Gastrointestinal Graft-versus-Host Disease Is a Risk Factor for Postengraftment Bloodstream Infection in Allogeneic Hematopoietic Stem Cell Transplant Recipients Reviewed

Yasuo Mori, Goichi Yoshimoto, Ruriko Nishida, Takeshi Sugio, Kohta Miyawaki, Takahiro Shima, Yoji Nagasaki, Noriko Miyake, Yukiko Harada, Yuya Kunisaki, Kenjiro Kamezaki, Akihiko Numata, Koji Kato, Motoaki Shiratsuchi, Takahiro Maeda, Katsuto Takenaka, Hiromi Iwasaki, Nobuyuki Shimono, Koichi Akashi, Toshihiro Miyamoto

Biology of Blood and Marrow Transplantation   24 ( 11 )   2302 - 2309   2018.11

Outcome of allogeneic hematopoietic cell transplantation in patients with adult T-cell leukemia Reviewed

Ayako Kamiunten, Masaaki Sekine, Takuro Kameda, Keiichi Akizuki, Yuki Tahira, Kotaro Shide, Haruko Shimoda, Koji Kato, Tomonori Hidaka, Yoko Kubuki, Kazuya Shimoda

Hematological Oncology   36 ( 4 )   651 - 655   2018.10

Microenvironmental immune cell signatures dictate clinical outcomes for PTCL-NOS Reviewed

Takeshi Sugio, Kohta Miyawaki, Koji Kato, Kensuke Sasaki, Kyohei Yamada, Javeed Iqbal, Toshihiro Miyamoto, Koichi Ohshima, Takahiro Maeda, Hiroaki Miyoshi, Koichi Akashi

Blood Advances   2 ( 17 )   2242 - 2252   2018.9

Effects of Prophylactic Foscarnet on Human Herpesvirus-6 Reactivation and Encephalitis in Cord Blood Transplant Recipients A Prospective Multicenter Trial with an Historical Control Group Reviewed

Masao Ogata, Kuniko Takano, Yukiyoshi Moriuchi, Tadakazu Kondo, Toshimitsu Ueki, Nobuaki Nakano, Takehiko Mori, Nobuhiko Uoshima, Koji Nagafuji, Satoshi Yamasaki, Yasuhiko Shibasaki, Rika Sakai, Koji Kato, Ilseung Choi, Yumi Jo, Tetsuya Eto, Shinichi Kako, Kumi Oshima, Takahiro Fukuda

Biology of Blood and Marrow Transplantation   24 ( 6 )   1264 - 1273   2018.6

A distinct subtype of epstein-barr virus-positive t/nk-cell lymphoproliferative disorder Adult patients with chronic active epstein-barr virus infection-like features Reviewed

Keisuke Kawamoto, Hiroaki Miyoshi, Takaharu Suzuki, Yasuji Kozai, Koji Kato, Masaharu Miyahara, Toshiaki Yujiri, Ilseung Choi, Katsumichi Fujimaki, Tsuyoshi Muta, Masaaki Kume, Sayaka Moriguchi, Shinobu Tamura, Takeharu Kato, Hiroyuki Tagawa, Junya Makiyama, Yuji Kanisawa, Yuya Sasaki, Daisuke Kurita, Kyohei Yamada, Joji Shimono, Hirohito Sone, Jun Takizawa, Masao Seto, Hiroshi Kimura, Koichi Ohshima

Haematologica   103 ( 6 )   1018 - 1028   2018.6

A distinct subtype of Epstein Barr virus positive T/NK-cell lymphoproliferative disorder: Adult patients with chronic active Epstein Barr virus infection-like features. Reviewed International journal

Kawamoto K, Miyoshi H, Suzuki T, Kozai Y, Kato K, Miyahara M, Yujiri T, Oishi N, Choi I, Fujimaki K, Muta T, Kume M, Moriguchi S, Tamura S, Kato T, Tagawa H, Makiyama J, Kanisawa Y, Sasaki Y, Kurita D, Yamada K, Shimono J, Sone H, Takizawa J, Seto M, Kimura H, Ohshima K.

Haematologica   103 ( 6 )   1018 - 1028   2018.6

Comparison of antiemetic effects of granisetron and palonosetron in patients receiving bendamustine-based chemotherapy. Reviewed International journal

Uchida M, Nakamura T, Makihara Y, Suetsugu K, Ikesue H, Mori Y, Kato K, Shiratsuchi M, Hosohata M, Myamoto T, Akashi K.

Pharmazie   73   304 - 308   2018.5

Risk Assessment in Adult T Cell Leukemia/Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation Reviewed

Makoto Yoshimitsu, Ryuji Tanosaki, Koji Kato, Takashi Ishida, Ilseung Choi, Yoshifusa Takatsuka, Takahiro Fukuda, Tetsuya Eto, Koji Kato, Naoyuki Uchida, Toshihiro Miyamoto, Yasuhiro Nakashima, Yukiyoshi Moriuchi, Koji Nagafuji, Yasuhiko Miyazaki, Tatsuo Ichinohe, Toshihiro Miyamoto, Yoshiko Atsuta, Atae Utsunomiya

Biology of Blood and Marrow Transplantation   24 ( 4 )   832 - 839   2018.4

Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets Invited Reviewed International journal

LEUKEMIA   32 ( 3 )   675 - 684   2018.3

Expression of PD-1 and PD-L1 on cytotoxic T lymphocytes and immune deficiency in a patient with adult T cell leukemia/lymphoma Reviewed

Toyoshi Yanagihara, Yuki Ikematsu, Koji Kato, Akiko Yonekawa, Satoko Ideishi, Taro Tochigi, Takeshi Sugio, Kohta Miyawaki, Kentaro Tanaka, Eiji Harada, Naoki Hamada, Yoichi Nakanishi

Annals of Hematology   97 ( 2 )   359 - 360   2018.2

Cyclophosphamide-induced tolerance in kidney transplantation avoids long-term immunosuppressive therapy Reviewed

Ario Takeuchi, Koji Kato, Koichi Akashi, Masatoshi Eto

International Journal of Urology   25 ( 2 )   112 - 120   2018.2

Follow-up of a randomised phase II study of chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma Impact on allogeneic haematopoietic stem cell transplantation Reviewed

Takashi Ishida, Tatsuro Jo, Shigeki Takemoto, Hitoshi Suzushima, Youko Suehiro, Ilseung Choi, Makoto Yoshimitsu, Yoshio Saburi, Kisato Nosaka, Atae Utsunomiya, Yukio Kobayashi, Kazuhito Yamamoto, Hiroshi Fujiwara, Kenji Ishitsuka, Shinichiro Yoshida, Naoya Taira, Kazunori Imada, Koji Kato, Yukiyoshi Moriuchi, Kenichi Yoshimura, Takeshi Takahashi, Kensei Tobinai, Ryuzo Ueda

British Journal of Haematology   2018.1

Safety, tolerability and pharmacokinetics of shorter duration of infusion of obinutuzumab in Japanese patients with B-cell non-Hodgkin lymphoma Final results of the phase II GATS study Reviewed

Ken Ohmachi, Kiyoshi Ando, Tomohiro Kinoshita, Kyoya Kumagai, Kiyohiko Hatake, Takayuki Ishikawa, Takanori Teshima, Koji Kato, Koji Izutsu, Eisuke Ueda, Kiyohiko Nakai, Hiroshi Kuriki, Kensei Tobinai

Japanese journal of clinical oncology   48 ( 8 )   736 - 742   2018.1

Mycobacterium abscessus and massiliense lung infection during macrolide treatment for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation Reviewed

Noriko Miyake, Yong Jeong, Ruriko Nishida, Katsuto Takenaka, Koji Kato, Toshihiro Miyamoto, Akio Aono, Akiko Takaki, Satoshi Mitarai, Shinji Shimoda, Nobuyuki Shimono, Koichi Akashi

Journal of Infection and Chemotherapy   24 ( 1 )   78 - 81   2018.1

Comparison of antiemetic effects of granisetron and palonosetron in patients receiving bendamustine-based chemotherapy Reviewed

M. Uchida, T. Nakamura, Y. Makihara, K. Suetsugu, H. Ikesue, Yasuo Mori, Koji Kato, Motoaki Shiratsuchi, K. Hosohata, Toshihiro Miyamoto, Koichi Akashi

Pharmazie   73 ( 5 )   304 - 308   2018.1

Comparative quantification of chemotherapy-induced nausea and emesis between the common terminology criteria for adverse events and the multinational association of supportive care in cancer antiemesis tool Reviewed

Mayako Uchida, Tsutomu Nakamura, Takahiro Shima, Goichi Yoshimoto, Koji Kato, Keiko Hosohata, Toshihiro Miyamoto, Koichi Akashi

Biological and Pharmaceutical Bulletin   41 ( 11 )   1667 - 1671   2018.1

A retrospective analysis of haplo-identical HLA-mismatch hematopoietic transplantation without posttransplantation cyclophosphamide for GVHD prophylaxis in patients with adult T-cell leukemia–lymphoma Reviewed

2018.1

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma. Reviewed International journal

N Engl J Med   378 ( 4 )   331 - 344   2018.1

Hepatitis C virus infection is an independent prognostic factor in follicular lymphoma Reviewed International journal

Joji Shimono, Hiroaki Miyoshi, Takeharu Kato, Takeshi Sugio, Kohta Miyawaki, Tomohiko Kamimura, Takuto Miyagishima, Tetsuya Eto, Yoshitaka Imaizumi, Koji Kato, Koji Nagafuji, Koichi Akashi, Masao Seto, Takanori Teshima, Koichi Ohshima

Oncotarget   9 ( 2 )   1717 - 1725   2018.1

Successful treatment of Ph ALL with hematopoietic stem cell transplantation from the same HLA-haploidentical related donor of previous liver transplantation Reviewed International journal

Sasaki K, Mori Y, Yoshimoto G, Sakoda T, Kato K, Inadomi K, Kamezaki K, Takenaka K, Iwasaki H, Maeda T, Miyamoto T, Akashi K

Leukemia and Lymphoma   1 - 3   2017.11

Identification of unipotent megakaryocyte progenitors in human hematopoiesis Reviewed

Kohta Miyawaki, Hiromi Iwasaki, Takashi Jiromaru, Hirotake Kusumoto, Ayano Yurino, Takeshi Sugio, Yasufumi Uehara, Jun Odawara, Shinya Daitoku, Yuya Kunisaki, Yasuo Mori, Yojiro Arinobu, Hirofumi Tsuzuki, Yoshikane Kikushige, Tadafumi Iino, Koji Kato, Katsuto Takenaka, Toshihiro Miyamoto, Takahiro Maeda, Koichi Akashi

Blood   129 ( 25 )   3332 - 3343   2017.6

Comparative analysis of pulmonary hypertension in patients treated with imatinib, nilotinib and dasatinib Reviewed

Mariko Minami, Takeshi Arita, Hiromi Iwasaki, Tsuyoshi Muta, Takatoshi Aoki, Kenichi Aoki, Satoshi Yamasaki, Takamitsu Matsushima, Koji Kato, Katsuto Takenaka, Kazuki Tanimoto, Tomohiko Kamimura, Ryosuke Ogawa, Koichi Akashi, Toshihiro Miyamoto

British Journal of Haematology   177 ( 4 )   578 - 587   2017.5

Severe Aplastic Anemia during Osimertinib Therapy in a Patient with EGFR Tyrosine Kinase Inhibitor–Resistant Non–Small Cell Lung Cancer Reviewed

12 ( 5 )   e46 - e47   2017.5

Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified Reviewed

Keisuke Kawamoto, Hiroaki Miyoshi, Eriko Yanagida, Noriaki Yoshida, Junichi Kiyasu, Yasuji Kozai, Tatsuma Morikita, Takeharu Kato, Hitoshi Suzushima, Shinobu Tamura, Tsuyoshi Muta, Koji Kato, Tetsuya Eto, Ritsuko Seki, Koji Nagafuji, Hirohito Sone, Jun Takizawa, Masao Seto, Koichi Ohshima

European Journal of Haematology   98 ( 5 )   459 - 466   2017.5

Mobilization of human immature hematopoietic progenitors through combinatory use of bortezomib and immunomodulatory drugs Reviewed

Taro Tochigi, Takatoshi Aoki, Yoshikane Kikushige, Tomohiko Kamimura, Yoshikiyo Ito, Takahiro Shima, Takuji Yamauchi, Yasuo Mori, Goichi Yoshimoto, Kenjiro Kamezaki, Koji Kato, Katsuto Takenaka, Hiromi Iwasaki, Koichi Akashi, Toshihiro Miyamoto

International Journal of Hematology   105 ( 4 )   423 - 432   2017.4

Dismal outcome of allogeneic hematopoietic stem cell transplantation for relapsed adult T-cell leukemia/lymphoma, a Japanese nation-wide study Reviewed

H. Fujiwara, S. Fuji, A. Wake, Koji Kato, Y. Takatsuka, T. Fukuda, J. Taguchi, N. Uchida, Toshihiro Miyamoto, M. Hidaka, Y. Miyazaki, T. Tomoyose, M. Onizuka, M. Takanashi, T. Ichinohe, Y. Atsuta, A. Utsunomiya,

Bone Marrow Transplantation   52 ( 3 )   484 - 488   2017.3

Graft-versus-host disease targets ovary and causes female infertility in mice Reviewed

Sonoko Shimoji, Daigo Hashimoto, Hidetsugu Tsujigiwa, Kohta Miyawaki, Koji Kato, Shuichiro Takahashi, Reiki Ogasawara, Takashi Jiromaru, Hiromi Iwasaki, Toshihiro Miyamoto, Koichi Akashi, Takanori Teshima

Blood   129 ( 9 )   1216 - 1225   2017.3

Comparison of cyclosporine and tacrolimus combined with mycophenolate mofetil in prophylaxis for graft-versus-host disease after reduced-intensity umbilical cord blood transplantation Reviewed International journal

Miyamoto T, Takashima S, Kato K, Takase K, Yoshimoto G, Yoshida S, Henzan H, Osaki K, Kamimura T, Iwasaki H, Eto T, Teshima T, Nagafuji K, Akashi K

INTERNATIONAL JOURNAL OF HEMATOLOGY   105 ( 1 )   92 - 99   2017.1

Recurrent subcutaneous sweet’s disease in a myelofibrosis patient treated with ruxolitinib before allogeneic stem cell transplantation Reviewed

56 ( 18 )   2481 - 2485   2017.1

Comparison between antiemetic effects of palonosetron and granisetron on chemotherapy-induced nausea and vomiting in Japanese patients treated with R-CHOP Reviewed

Mayako Uchida, Yasuo Mori, Tsutomu Nakamura, Koji Kato, Kenjiro Kamezaki, Katsuto Takenaka, Motoaki Shiratsuchi, Kaori Kadoyama, Toshihiro Miyamoto, Koichi Akashi

Biological and Pharmaceutical Bulletin   40 ( 9 )   1499 - 1505   2017.1

PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia/lymphoma Reviewed International journal

Miyoshi H, Kiyasu J, Kato T, Yoshida N, Shimono J, Yokoyama S, Taniguchi H, Sasaki Y, Kurita D, Kawamoto K, Kato K, Imaizumi Y, Seto M, Ohshima K

Blood   128 ( 10 )   1374 - 1381   2016.9

Enhanced Reconstitution of Human Erythropoiesis and Thrombopoiesis in an Immunodeficient Mouse Model with Kit(Wv) Mutations Reviewed International journal

Yurino A, Takenaka K, Yamauchi T, Nunomura T, Uehara Y, Jinnouchi F, Miyawaki K, Kikushige Y, Kato K, Miyamoto T, Iwasaki H, Kunisaki Y, Akashi K

STEM CELL REPORTS   7 ( 3 )   425 - 438   2016.9

Pretransplant anti-CCR4 antibody mogamulizumab against ATLL is associated with significantly increased risks of severe and steroid-refractory GVHD, non-relapse mortality and overall mortality. Reviewed International journal

Fuji S, Inoue Y, Utsunomiya A, Moriuchi Y, Uchimaru K, Choi I, Otsuka E, Henzan H, Kato K, Tomoyose T, Yamamoto H, Kurosawa S, Matsuoka K, Yamaguchi T, Fukuda T

J Clin Oncol.   34   3426 - 3433   2016.9

Mogamulizumab treatment prior to allogeneic hematopoietic stem cell transplantation induces severe acute graft-versus-host disease. Invited Reviewed International journal

Sugio T*, Kato K*, Aoki T, Ohta T, Saito N, Yoshida S, Kawano I, Henzan H, Kadowaki M, Takase K, Muta T, Miyawaki K, Yamauchi T, Shima T, Takashima S, Mori Y, Yoshimoto G, Kamezaki K, Takenaka KIwasaki H, Ogawa R, Ohno Y, Eto T, Kamimura T, Miyamoto T, Akashi K (*Equal contribution to this work).

Biol Blood Marrow Transplant.   2016.5

Ascites Retention during Mogamulizumab Treatment in a Patient with Adult T-cell Leukemia/lymphoma Invited Reviewed International journal

Shima T, Kamezaki K, Higashioka K, Takashima S, Yoshimoto G, Kato K, Muta T, Takenaka K, Iwasaki H, Miyamoto T, Akashi K

INTERNAL MEDICINE   55 ( 13 )   1793 - 1796   2016.5

Cord Blood Transplantation Following Reduced-intensity Conditioning for Adult-onset Inherited Hemophagocytic Lymphohistiocytosis Invited Reviewed International journal

Kuriyama T, Kato K, Sakamoto K, Hayashi M, Takashima S, Mori Y, Takenaka K, Iwasaki H, Teshima T, Harada N, Nagafuji K, Miyamoto T, Akashi K

INTERNAL MEDICINE   55 ( 6 )   667 - 671   2016.3

Effects of conditioning intensity in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia Invited Reviewed International journal

Takashima S, Miyamoto T, Kamimura T, Yoshimoto G, Yoshida S, Henzan H, Takase K, Kato K, Ito Y, Ohno Y, Nagafuji K, Eto T, Teshima T, Akashi K

INTERNATIONAL JOURNAL OF HEMATOLOGY   102 ( 6 )   689 - 696   2015.12

Successful treatment of adult Langerhans cell histiocytosis with intensified chemotherapy Reviewed International journal

Minami M, Shima T, Kato K, Yamamoto H, Tsuchihashi K, Oku S, Shimokawa T, Tochigi T, Yoshimoto G, Kamezaki K, Takenaka K, Iwasaki H, Oda Y, Miyamoto T, Akashi K

Int J Hematol.   102 ( 2 )   244 - 248   2015.8

α-Mannan induces Th17-mediated pulmonary graft-versus-host disease in mice. Reviewed International journal

2015.5

Characteristics of patients with development of large granular lymphocytes expansion among dasatinib-treated patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic stem cell transplantation Reviewed International journal

Ito Y, Miyamoto T, Kamimura T, Aoki K, Henzan H, Aoki T, Shiratsuchi M, Kato K, Nagafuji K, Ogawa R, Eto T, Iwasaki H, Akashi K

Clinical Lymphoma Myeloma and Leukemia 2015; 15: e47-54.   2015.2

The role of hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma Reviewed International journal

Kako S, Izutsu K, Kato K, Kim Sung-Won, Mori T, Fukuda T, Kobayashi N, Taji H, Hashimoto H, Kondo T, Sakamaki H, Morishima Y, Kato K, Suzuki R, Suzumiya J

AMERICAN JOURNAL OF HEMATOLOGY   90 ( 2 )   2015.2

α-Mannan induces Th17-mediated pulmonary graft-versus-host disease in mice Reviewed

125 ( 19 )   3014 - 3023   2015.1

Treatment of Patients with Adult T Cell Leukemia/Lymphoma with Cord Blood Transplantation: A Japanese Nationwide Retrospective Survey Reviewed International journal

Kato K, Choi I, Wake A, Uike N, Taniguchi S, Moriuchi Y, Miyazaki Y, Nakamae H, Oku E, Murata M, Eto T, Akashi K, Kato K, Suzuki R, Yamanaka T, Utsunomiya A

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION   20 ( 12 )   2014.12

Long-term remission after high-dose chemotherapy followed by auto-SCT as consolidation for intravascular large B-cell lymphoma Reviewed International journal

Kato K, Ohno Y, Kamimura T, Kusumoto H, Tochigi T, Jinnouchi F, Kohno K, Kuriyama T, Henzan H, Takase K, Kawano I, Kadowaki M, Nawata R, Muta T, Eto T, Iawasaki H, Ohshima K, Miyamoto T, Akashi K

BONE MARROW TRANSPLANTATION   49 ( 12 )   2014.12

The ordered acquisition of Class II and Class I mutations directs formation of human t(8;21) acute myelogenous leukemia stem cell

Shima T, Miyamoto T, Kikushige Y, Yuda J, Tochigi T, Yoshimoto G, Kato K, Takenaka K, Iwasaki H, Mizuno S, Goto N, Akashi K

EXPERIMENTAL HEMATOLOGY   42 ( 11 )   2014.11

A Case Report of Malignant Lymphoma Receiving Infliximab Therapy with Behçet's Disease. Reviewed

2014.9

The use of oral beclomethasone dipropionate in the treatment of gastrointestinal graft-versus-host disease: the experience of the Fukuoka blood and marrow transplantation (BMT) group. Reviewed International journal

Takashima S, Eto T, Shiratsuchi M, Mori Yasuo, Kato K, Kamezaki K, Oku S, Henzan H, Takase K, Matsushima T, Takenaka K, Iwasaki H, Miyamoto T, Akashi K, Teshima T

Intern Med   2014.8

Combination of bortezomib, thalidomide, and dexamethasone (VTD) as a consolidation therapy after autologous stem cell transplantation for symptomatic multiple myeloma in Japanese patients

Takashima S, Miyamoto T, Kadowaki M, Ito Y, Aoki T, Takase K, Shima T, Yoshimoto G, Kato Koji, Muta T, Shiratsuchi M, Takenaka K, Iwasaki H, Teshima T, Kamimura T, Akashi K

INTERNATIONAL JOURNAL OF HEMATOLOGY   100 ( 2 )   2014.8

Comparison of bortezomib, cyclophosphamide, and dexamethasone (VCD) induction with bortezomib and dexamethasone (BD) induction for newly diagnosed symptomatic multiple myeloma. Reviewed International journal

Takashima S, Kamimura T, Miyamoto T, Yoshimoto G, Kato K, Ito Y, Muta T, Matsushima T, Shiratsuchi M, Tanimoto K, Takenaka K, Iwasaki H, Teshima T, Akashi K

International Journal of Myeloma.   2014.4

Successful treatment of invasive zygomycosis based on a prompt diagnosis using molecular methods in a patient with acute myelogenous leukemia. Reviewed International journal

Yuda J, Kato K, Kikushige Y, Ohkusu K, Kiyosuke M, Sakamoto K, Oku S, Miyake N, Kadowaki M, Iino T, Tanimoto K, Takenaka K, Iwasaki H, Miyamoto T, Shimono N, Teshima T, Akashi K

Intern Med.   2014.4

High-dose chemotherapy with autologous stem cell transplantation for elderly patients with relapsed/refractory diffuse large B-cell lymphoma: a nationwide retrospective study. Reviewed International journal

Chihara D, Izutsu K, Kondo E, Sakai R, Mizuta S, Yokoyama K, Kaneko H, Kato K, Hasegawa Y, Chou T, Sugahara H, Henzan H, Sakamaki H, Suzuki R, Suzumiya J

Biol Blood Marrow Transplant.   2014.1

Impact of Graft-versus-Host Disease on Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Leukemia-Lymphoma Focusing on Preconditioning Regimens: Nationwide Retrospective Study Reviewed International journal

Ishida T, Hishizawa M, Kato K, Tanosaki R, Fukuda T, Takatsuka Y, Eto T, Miyazaki Y, Hidaka M, Uike N, Miyamoto T, Tsudo M, Sakamaki H, Morishima Y, Suzuki R, Utsunomiya A

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION   19 ( 12 )   2013.12

Superiority of tandem autologous stem cell transplantation using high dose melphalan for patients with multiple myeloma Reviewed International journal

Muta T, Kamimura T, Miyamoto T, Ohno Y, Henzan T, Kato K, Takenaka K, Iwasaki H, Fujisaki T, Eto T, Akashi K

International Journal of Myeloma.   2013.12

Clinical outcomes of allogeneic stem cell transplantation for relapsed or refractory follicular lymphoma: a retrospective analysis by the Fukuoka Blood and Marrow Transplantation Group Reviewed International journal

Ito Y, Miyamoto T, Kamimura T, Takase K, Henzan H, Sugio Y, Kato K, Ohno Y, Eto T, Teshima T, Akashi K

INTERNATIONAL JOURNAL OF HEMATOLOGY   98 ( 4 )   2013.10

Reduced-intensity conditioning followed by cord blood transplantation in a patient with refractory folliculotropic mycosis fungoides Reviewed International journal

Nakaike T, Kato K, Oku S, Hayashi M, Kikushige Y, Kuroiwa M, Takenaka K, Iwasaki H, Miyamoto T, Teshima T, Ohshima K, Akashi K

INTERNATIONAL JOURNAL OF HEMATOLOGY   98 ( 4 )   2013.10

Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma Reviewed International journal

Miyamoto T, Yoshimoto G, Kamimura T, Muta T, Takashima S, Ito Y, Shiratsuchi M, Choi I, Kato K, Takenaka K, Iwasaki H, Takamatsu Y, Teshima T, Akashi K

INTERNATIONAL JOURNAL OF HEMATOLOGY   98 ( 3 )   2013.9

Effectiveness and safety of antiemetic aprepitant in Japanese patients receiving high-dose chemotherapy prior to autologous hematopoietic stem cell transplantation Reviewed International journal

Uchida M, Ikesue H, Miyamoto T, Kato K, Suetsugu K, Ichinose K, Hiraiwa H, Sakurai A, Takenaka K, Muta T, Iwasaki H, Teshima T, Shiratsuchi M, Egashira N, Akashi K, Oishi R

Biol Pharm Bull   2013.7

Evaluating the association between histological manifestations of cord colitis syndrome with GVHD. Reviewed International journal

Sonoko Shimoji, Koji Kato, Yoshihiro Eriguchi, Katsuto Takenaka, Hiromi IWASAKI, Toshihiro Miyamoto, Yoshinao Oda, koichi akashi, Takanori Teshima

Bone Marrow Transplant   2013.6

Effect of bortezomib-based induction therapy on the peripheral blood stem cell harvest in multiple myeloma. Reviewed

Muta T., Miyamoto T., Fujisaki T., Ohno Y., Kamimura T., Henzan T., Kato K., Takenaka K., Iwasaki H., Eto T., Takamatsu Y., Teshima T., Akashi K

Rinsho Ketsueki   2013.4

Standardization of image quality across multiple centers by optimization of acquisition and reconstruction parameters with interim FDG-PET/CT for evaluating diffuse large B cell lymphoma

Hiromitsu Daisaki, Ukihide Tateishi, Takashi Terauchi, Mitsuaki Tatsumi, Kazufumi Suzuki, Naoki Shimada, Hiroyuki Nishida, Akihiko Numata, Koji Kato, Koichi Akashi, Mine Harada

ANNALS OF NUCLEAR MEDICINE   27 ( 3 )   2013.4

Decrease in Venous Irritation by Adjusting the Concentration of Injected Bendamustine

Hiroyuki Watanabe, Hiroaki Ikesue, Tomoko Tsujikawa, Kenichiro Nagata, Mayako Uchida, Kimitaka Suetsugu, Nobuaki Egashira, Tsuyoshi Muta, Koji Kato, Katsuto Takenaka, Saiji Ohga, Takamitsu Matsushima, Motoaki Shiratsuchi, Toshihiro Miyamoto, Takanori Teshima, Koichi Akashi, Ryozo Oishi

BIOLOGICAL & PHARMACEUTICAL BULLETIN   36 ( 4 )   2013.4

Potential Contribution of a Novel Tax Epitope-Specific CD4(+) T Cells to Graft-versus-Tax Effect in Adult T Cell Leukemia Patients after Allogeneic Hematopoietic Stem Cell Transplantation Reviewed International journal

Yotaro Tamai, Atsuhiko Hasegawa, Ayako Takamori, Amane Sasada, Ryuji Tanosaki, Ilseung Choi, Atae Utsunomiya, Yasuhiro Maeda, Yoshihisa Yamano, Tetsuya Eto, Ki-Ryang Koh, Hirohisa Nakamae, Youko Suehiro, Koji Kato, Shigeki Takemoto, Jun Okamura, Naokuni Uike, Mari Kannagi

JOURNAL OF IMMUNOLOGY   190 ( 8 )   2013.4

Delta-like Ligand 4 Identifies a Previously Uncharacterized Population of Inflammatory Dendritic Cells That Plays Important Roles in Eliciting Allogeneic T Cell Responses in Mice Reviewed International journal

Kazuhiro Mochizuki, Fang Xie, Shan He, Qing Tong, Yongnian Liu, Izumi Mochizuki, Yajun Guo, Koji Kato, Hideo Yagita, Shin Mineishi, Yi Zhang

JOURNAL OF IMMUNOLOGY   190 ( 7 )   2013.4

Efficacy and Safety of Aprepitant in Allogeneic Hematopoietic Stem Cell Transplantation. Reviewed International journal

Mayako Uchida, Koji Kato, Hiroaki Ikesue, Kimiko Ichinose, Hiromi Hiraiwa, Akiko Sakurai, Tsuyoshi Muta, Katsuto Takenaka, Toshihiro Miyamoto, Hiromi IWASAKI, Takanori Teshima, Motoaki Shiratsuchi, K Suetsugu, K Nagata, Nobuaki Egashira, koichi akashi, Ryozo Oishi

Pharmacotherapy   2013.4

Diffuse panbronchiolitis after humanized anti-CCR4 monoclonal antibody therapy for relapsed adult T-cell leukemia/lymphoma Reviewed International journal

Koji Kato, Toshihiro Miyamoto, Akihiko Numata, Takashi Nakaike, Hideyo Oka, Ayano Yurino, Takuro Kuriyama, Yasuo Mori, Satoshi Yamasaki, Tsuyoshi Muta, Katsuto Takenaka, Hiromi Iwasaki, Takanori Teshima, Koichi Akashi

INTERNATIONAL JOURNAL OF HEMATOLOGY   97 ( 3 )   2013.3

Evaluation of the Feasibility and Efficacy of Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma Reviewed International journal

Tsuyoshi Muta, Toshihiro Miyamoto, Tomoaki Fujisaki, Yuju Ohno, Tomohiko Kamimura, Koji Kato, Katsuto Takenaka, Hiromi Iwasaki, Tetsuya Eto, Yasushi Takamatsu, Takanori Teshima, Koichi Akashi

INTERNAL MEDICINE   52 ( 1 )   2013.2

Antiemetic effectiveness and safety of aprepitant in patients with hematologic malignancy receiving multiday chemotherapy

Mayako Uchida, Hiroaiu Ikesue, Koji Kato, Kimiko Ichinose, Hiromi Hiraiwa, Asako Sakurai, Katsuto Takenaka, Hiromi Iwasaki, Toshihiro Miyamoto, Takanori Teshima, Nobuaki Egashira, Koichi Akashi, Ryozo Oishi

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY   70 ( 4 )   2013.2

Successful treatment with anti-CC chemokine receptor 4 MoAb of relapsed adult T-cell leukemia/lymphoma after umbilical cord blood transplantation Reviewed International journal

Ito Y, Miyamoto T, Chong Y, Aoki T, Kato K, Akashi K, Kamimura T

Bone Marrow Transplant.   2013.1

Quantitation of hematogones at the time of engraftment is a useful prognostic indicator in allogeneic hematopoietic stem cell transplantation Reviewed International journal

Takahiro Shima, Toshihiro Miyamoto, Kikushige Yoshikane, Mori Yasuo, Kenjirou Kamezaki, Takase Ken, Henzan Hideho, Numata Akihiko, Ito Yoshikiyo, Katsuto Takenaka, Hiromi IWASAKI, Kamimura Tomohiko, Eto Tetsuya, Nagafuji Koji, Takanori Teshima, Koji Kato, Koichi Akashi

Blood.   121 ( 5 )   2013.1

Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study Reviewed International journal

Takashi Ishida, Masakatsu Hishizawa,, Koji Kato, Ryuji Tanosaki,, Takahiro Fukuda, Shuichi Taniguchi, Tetsuya Eto, Yoshifusa Takatsuka, Yasushi Miyazaki, Yukiyoshi Moriuchi, Michihiro Hidaka, Koichi Akashi, Naokuni Uike, Hisashi Sakamaki, Yasuo Morishima, Koji Kato, Ritsuro Suzuki, Takeshi Nishiyama, Atae Utsunomiya

Blood.   120 ( 8 )   2012.8

Low incidence of adenovirus hemorrhagic cystitis following autologous hematopoietic stem cell transplantation in the rituximab era Reviewed International journal

Yasuo Mori, Toshihiro Miyamoto, Kenjirou Kamezaki, Koji Kato, Yoshikane Kikushige, Takashima Shuichiro, Shingo Urata, Shinji Shimoda, Nobuyuki Shimono, Katsuto Takenaka, Hiromi IWASAKI, koji nagafuji, Takanori Teshima, Koichi Akashi

Am J Hematol.   87 ( 8 )   2012.8

Initial low-dose valganciclovir as a preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients. Reviewed International journal

Takenaka K, Nagafuji K, Takase K, Kamimura T, Mori Y, Ito Y, Nishi Y, Henzan H, Kato K, Harada N, Eto T, Miyamoto T, Teshima T, Akashi K.

Int J Hematol.   2012.5

Different Risk Factors Related to Adenovirus- or BK Virus-Associated Hemorrhagic Cystitis following Allogeneic Stem Cell Transplantation. Reviewed International journal

Mori Y, Miyamoto T, Kato K, Kamezaki K, Kuriyama T, Oku S, Takenaka K, Iwasaki H, Harada N, Shiratsuchi M, Abe Y, Nagafuji K, Teshima T, Akashi K.

Biol Blood Marrow Transplant.   2012.4

Validation of pretransplantation assessment of mortality risk score in the outcome of hematopoietic SCT in non-Caucasians. Reviewed International journal

Mori Y, Teshima T, Kamezaki K, Kato K, Takenaka K, Iwasaki H, Miyamoto T, Nagafuji K, Eto T, Akashi K.

Bone Marrow Transplant.   2011.11

Inhibition of histone methylation arrests ongoing graft-versus-host disease in mice by selectively inducing apoptosis of alloreactive effector T cells. Reviewed International journal

He S*, Wang J*, Kato K*, Xie F, Varambally S, Mineishi S, Kuick R, Mochizuki K, Liu Y, Nieves E, Mani RS, Chinnaiyan AM, Marquez VE, Zhang Y. (*Equal contribution to this work)

Blood   2011.11

Diagnostic value of serum procalcitonin and C-reactive protein for infections after allogeneic hematopoietic stem cell transplantation versus nontransplant setting. Reviewed International journal

Mori Y, Miyawaki K, Kato K, Takenaka K, Iwasaki H, Harada N, Miyamoto T, Akashi K, Teshima T.

Intern Med.   2011.9

Characterization of the metabolic phenotype of rapamycin-treated CD8+ T cells with augmented ability to generate long-lasting memory cells. Reviewed International journal

He S*, Kato K*, Jiang J, Wahl DR, Mineish S, Fisher EM, Murasko DM, Glick GD, Zhang Y (*Equal contribution to this work).

PLoS ONE.   2011.5

Notch signaling is a critical regulator of allogeneic CD4+ T cell responses mediating graft-versus-host disease. Reviewed International journal

Zhang Y, Sandy AR, Wang J, Radojcic V, Shan GT, Tran IT, Friedman A, Kato K, He S, Cui S, Hexner E, Frank DM, Emerson SG, Pear WS, Maillard I.

Blood   2011.2

High incidence of HHV6-associated encephalitis/myelitis following a second unrelated cord blood transplantation. Reviewed International journal

Mori Y, Miyamoto T, Nagafuji K, Kamezaki K, Yamamoto A, Saito N, Kato K, Takenaka K, Iwasaki H, Harada N, Abe Y, Teshima T, Akashi K.

Biol Blood Marrow Transplant.   2010.10

Identification of stem cell transcriptional programs normally expressed in embryonic and neural stem cells in alloreactive CD8(+) T cells mediating graft-versus-host disease. Reviewed International journal

Kato K, Cui S, Kuick R, Mineishi S, Hexner E, Ferrara JL, Emerson SG, Zhang Y.

Biol Blood Marrow Transplant.   2010.1

Reduced intensity versus full myeloablative stem cell transplant for advanced CLL. Reviewed International journal

Peres E, Braun T, Krijanovski O, Khaled Y, Levine JE, Yanik G, Kato K, Mineishi S.

Bone Marrow Transplant.   2009.10

Long-term outcomes of autologous PBSCT for peripheral T-cell lymphoma: retrospective analysis of the experience of the Fukuoka BMT group. Reviewed International journal

Numata A, Miyamoto T, Ohno Y, Kamimura T, Kamezaki K, Tanimoto T, Takase K, Henzan H, Kato K, Takenaka K, Fukuda T, Harada N, Nagafuji K, Teshima T, Akashi K, Harada M and Eto T for the Fukuoka Blood and Marrow Transplantation Group.

Bone Marrow Transplant.   2009.10

Outcomes after auto-SCT in African Americans with multiple myeloma. Reviewed International journal

Khaled Y, Abidi MH, Janakiraman N, Kato K, Levine JE, Reddy P, Medina M, Peres E, Hanbali A, Mineishi S.

Bone Marrow Transplant.   2009.6

The consequenses of tacrolimus blood concentrations during the four weeks following marrow transplantation from an unrelated donor: a single-center experience. Reviewed

Muta T, Kato K, Gondo H, Oku S, Okeda A, Kamo M, Nawata R, Takase K, Arima F, Shibuya T, Eto T.

Jpn J Cancer Chemother.   2008.6

The consequences of tacrolimus blood concentrations during the four weeks following marrow transplantation from an unrelated donor a single-center experience. Reviewed

Tsuyoshi Muta, Koji Kato, Hisashi Gondo, Seido Oku, Aki Okeda, Mieko Kamo, Ryohei Nawata, Ken Takase, Fumito Arima, Tsunefumi Shibuya, Testuya Eto

Gan to kagaku ryoho. Cancer & chemotherapy   35 ( 1 )   99 - 104   2008.1

Early Relapses Do Not Impact Survival after Autologous Stem Cell Transplantation in African Americans with Multiple Myeloma. Reviewed International journal

Khaled Y, Kato K, Janakiraman N, Ferrara JLM, Mineishi S.

Bone Marrow Transplant.   2007.10

Successful mobilization of peripheral blood stem cells in an acute promyelocytic leukemia patient after gemtuzumab ozogamicin [3] Reviewed

T. Muta, K. Kato, S. Oku, R. Nawata, K. Takase, H. Henzan, F. Arima, T. Eto

Bone Marrow Transplantation   40 ( 3 )   287 - 288   2007.8

Rituximab Does Not Compromise the Mobilization and Engraftment of Autologous Peripheral Blood Stem Cells in Diffuse-Large B-cell Lymphoma. Reviewed International journal

Kamezaki K, Kikushige Y, Numata A, Takase K, Henzan H, Aoki K, Kato K, Nonami A, Kamimura T, Arima F, Takenaka K, Harada N, Fukuda T, Hayashi S, Ohno Y, Eto T, Harada M, Nagafuji K.

Bone Marrow Transplant.   2007.7

Early relapses do not impact survival after autologous stem cell transplantation in African Americans with multiple myeloma [2] Reviewed

Y. Khaled, Koji Kato, N. Janakiraman, J. L.M. Ferrara, S. Mineishi

Bone Marrow Transplantation   39 ( 11 )   727 - 728   2007.6

Reduced-intensity stem cell transplantation for hematological malignancies Current status and the future Reviewed

Koji Kato, Yasser Khaled, Shin Mineishi

Current Stem Cell Research and Therapy   2 ( 2 )   149 - 162   2007.5

Rituximab does not compromise the mobilization and engraftment of autologous peripheral blood stem cells in diffuse-large B-cell lymphoma Reviewed

K. Kamezaki, Y. Kikushige, A. Numata, T. Miyamoto, K. Takase, H. Henzan, K. Aoki, K. Kato, A. Nonami, T. Kamimura, F. Arima, K. Takenaka, N. Harada, T. Fukuda, S. Hayashi, Y. Ohno, T. Eto, M. Harada, K. Nagafuji

Bone Marrow Transplantation   39 ( 9 )   523 - 527   2007.5

A nosocomial outbreak due to novel CTX-M-2-producing strains of Citrobacter koseri in a hematological ward. Reviewed

Muta T, Tsuruta N, Seki Y, Ota R, Suzuki S, Shibata N, Kato K, Eto T, Gondo H, Arakawa Y.

Jpn J Infect Dis.   2007.1

Successful stem cell transplantation without cryopreservation from a microchimeric haploidentical sibling for refractory acute myeloid leukemia complicated with critical thrombophlebitis and cellulitis Reviewed

Tsuyoshi Muta, Koji Kato, Testuya Eto, Seido Oku, Ryohei Nawata, Ken Takase, Hideho Henzan, Fumito Arima, Hisashi Gondo, Takashi Okamura, Tsunefumi Shibuya

International journal of hematology   85 ( 1 )   85 - 88   2007.1

Allogeneic Bone Marrow Transplantation from Unrelated Human T-Cell Leukemia Virus-I-negative Donors for Adult T-Cell Leukemia/Lymphoma Retrospective Analysis of Data from the Japan Marrow Donor Program Reviewed

Koji Kato, Yoshinobu Kanda, Tetsuya Eto, Tsuyoshi Muta, Hisashi Gondo, Shuichi Taniguchi, Tsunefumi Shibuya, Atae Utsunomiya, Takakazu Kawase, Shunichi Kato, Yasuo Morishima, Yoshihisa Kodera, Mine Harada

Biology of Blood and Marrow Transplantation   13 ( 1 )   90 - 99   2007.1

Allogeneic bone marrow transplantation from unrelated HTLV-I-negative donors for adult T-cell leukemia/lymphoma: retrospective analysis of data from the Japan marrow donor program. Reviewed International journal

Kato K, Kanda Y, Eto T, Muta T, Gondo H, Taniguchi S, Shibuya T, Utsunomiya A, Kawase T, Kato S, Morishima Y, Kodera Y, Harada M for the Japan marrow donor program.

Biol Blood Marrow Transplant.   2007.1

Acute lymphoblastic leukemia presenting with calcineurin-inhibitor induced pain syndrome after a second allogeneic bone marrow transplantation Reviewed

Shuichiro Takashima, Akihiko Numata, Toshihiro Miyamoto, Tsuyoshi Shirakawa, Rieko Kinoshita, Kouji Kato, Katsuto Takenaka, Naoki Harada, Koji Nagafuji, Shuichi Taniguchi, Mine Harada

47 ( 10 )   1372 - 1376   2006.10

A nosocomial outbreak due to novel CTX-M-2 producing strains of Citrobacter koseri in a hematological ward Reviewed

Tsuyoshi Muta, Nobuko Tsuruta, Yumiko Seki, Rika Ota, Satowa Suzuki, Naohiro Shibata, Koji Kato, Tetsuya Eto, Hisashi Gondo, Yoshichika Arakawa

Japanese Journal of Infectious Diseases   59 ( 1 )   69 - 71   2006.3

Demonstration of reversed flow in segmental branches of the portal vein with hand-held color Doppler ultrasonography after hematopoietic stem cell transplantation. Reviewed International journal

Hashiguchi M, Okamura T, Yoshimoto K, Ono N, Imamura R, Yakushiji K, Ogata H, Seki R, Otsubo K, Oku E, Kuroiwa M, Higuchi M, Kato K, Taniguchi S, Gondo H, Shibuya T, Nagafuji K, Harada M and Sata M.

Bone Marrow Transplant.   36 ( 12 )   1071 - 1075   2005.10

FLT3 mutations in normal karyotype acute myeloid leukemia in first complete remission treated with autologous peripheral blood stem cell transplantation. Reviewed International journal

Yoshimoto G, Nagafuji K, Miyamoto T, Kinukawa N, Takase K, Eto T, Kato K, Hayashi S, Kamimura T, Ohno Y, Taniguchi S, Harada M.

Bone Marrow Transplant.   36 ( 11 )   977 - 983   2005.10

Mobilization of human lymphoid progenitors after treatment with granulocyte colony-stimulating factor Reviewed

Rie Imamura, Toshihiro Miyamoto, Goichi Yoshimoto, Kenjiro Kamezaki, Fumihiko Ishikawa, Hideho Henzan, Koji Kato, Ken Takase, Akihiko Numata, Koji Nagafuji, Takashi Okamura, Michio Sata, Mine Harada, Shoichi Inaba

Journal of Immunology   175 ( 4 )   2647 - 2654   2005.8

Successful therapy with argatroban for superior mesenteric vein thrombosis in a patient with congenital antithrombin deficiency Reviewed

Tsuyoshi Muta, Takashi Okamura, Masahiko Kawamoto, Hitoshi Ichimiya, Motoko Yamanaka, Yui Wada, Michiyo Urata, Yuzo Kayamori, Naotaka Hamasaki, Koji Kato, Testuya Eto, Hisashi Gondo, Tsunefumi Shibuya

European Journal of Haematology   75 ( 2 )   167 - 170   2005.8

Mobilization of human lymphoid progenitors after treatment with granulocyte colony-stimulating factor. Reviewed International journal

Imamura R, Miyamoto T, Yoshimoto G, Kamezaki K, Ishikawa F, Henzan H, Kato K, Takase K, Numata A, Nagafuji K, Okamura T, Sata M, Harada M, Inaba S.

J Immunol.   175 ( 4 )   2647 - 2654   2005.7

Present status in hematopoietic stem cell transplantation peripheral blood stem cell transplantation Reviewed

Koji Kato, Mine Harada

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine   94 ( 7 )   1281 - 1286   2005.7

Signal transducers and activators of transcription 3 augments the transcriptional activity of CCAAT/enhancer-binding protein alpha in granulocyte colony-stimulating factor signaling pathway. Reviewed International journal

Numata A, Shimoda K, Kamezaki K, Haro T, Kakumitsu H, Shide K, Kato K, Miyamoto T, Yamashita Y, Oshima Y, Nakajima H, Iwama A, Aoki K, Takase K, Gondo H, Mano H, Harada M.

J Biol Chem.   280 ( 13 )   12621 - 12629   2005.4

Human herpesvirus-6 encephalitis followed by severe acute GVHD after a stem cell transplant from a microchimeric non-inherited maternal antigen (NIMA)-mismatched sibling [1] Reviewed

T. Muta, M. Kamo, H. Gondo, K. Kato, T. Eto, T. Shibuya, T. Fukuda, T. Miyamoto, K. Nagafuji, T. Ichinohe, M. Harada

Bone Marrow Transplantation   35 ( 4 )   411 - 413   2005.2

Reduced-intensity hematopoietic stem cell transplantation for a patient with myelodysplastic syndrome and chronic obstructive pulmonary disease Reviewed

Kosuke Obama, Tetsuya Eto, Nobuko Tsuruta, Yuko Nagara, Aki Okeda, Koji Kato, Tsuyoshi Muta, Hisashi Gondo, Tsunefumi Shibuya

International journal of hematology   80 ( 5 )   470 - 471   2004.12

Reconstitution of HLA-A*2402-restricted cytomegalovirus-specific T-cells following stem cell transplantation. Reviewed International journal

Gondo H, Himeji D, Kamezaki K, Numata A, Tanimoto T, Takase K, Aoki K, Henzan H, Nagafuji K, Miyamoto T, Ishikawa F, Shimoda K, Inaba S, Tsukamoto H, Horiuchi T, Nakashima H, Otsuka T, Kato K, Kuroiwa M, Higuchi M, Shibuya T, Kamimura T, Kuzushima K, Tsurumi T, Kanda Y, Harada M.

Int J Hematol.   80 ( 5 )   441 - 448   2004.11

Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients. Reviewed International journal

Nagafuji K, Aoki K, Henzan H, Kato K, Miyamoto T, Eto T, Nagatoshi Y, Ohba T, Obama K, Gondo H, Harada M.

Bone Marrow Transplant.   34 ( 10 )   909 - 914   2004.8

Successful treatment of diffuse large b-cell lympoma following waldenström's macroglobulinemia with CHOP chemotherapy followed by combination therapy of CHOP with rituximab Reviewed

43 ( 2 )   131 - 134   2004.2

The lipocalin 24p3, which is an essential molecule in IL-3 withdrawal-induced apoptosis, is not involved in the G-CSF withdrawal-induced apoptosis. Reviewed International journal

Kamezaki K, Shimoda K, Numata A, Aoki K, Kato K, Takase K, Nakajima H, Ihara K, Haro T, Ishikawa F, Imamura R, Miyamoto T, Nagafuji K, Gondo H, Hara T, Harada M.

Eur J Haematol.   71 ( 6 )   412 - 417   2003.8

Intracellular signal transduction of interferon on the suppression of haematopoietic progenitor cell growth. Reviewed International journal

Kato K, Kamezaki K, Shimoda K, Numata A, Haro T, Aoki K, Ishikawa F, Takase K, Ariyama H, Matsuda T, Miyamoto T, Nagafuji K, Gondo H, Nakayama K, Harada M.

Br J Haematol.   123 ( 3 )   528 - 535   2003.5

Cutting edge Tyk2 is required for the induction and nuclear translocation of Daxx which regulates IFN-α-induced suppression of B lymphocyte formation Reviewed

169 ( 9 )   4707 - 4711   2002.11

Development of rheumatoid arthritis following autologous peripheral blood stem cell transplantation Reviewed

R. Imamura, H. Inoue, K. Kato, S. Kobayashi, H. Tsukamoto, K. Nagafuji, K. Shimoda, H. Nakashima, T. Otsuka, H. Gondo, M. Harada

Bone Marrow Transplantation   30 ( 8 )   527 - 529   2002.10

Cutting edge: tyk2 is required for the induction and nuclear translocation of Daxx which regulates IFN-alpha-induced suppression of B lymphocyte formation. Reviewed International journal

Shimoda K, Kamesaki K, Numata A, Aoki K, Matsuda T, Oritani K, Tamiya S, Kato K, Takase K, Imamura R, Yamamoto T, Miyamoto T, Nagafuji K, Gondo H, Nagafuchi S, Nakayama K, Harada M.

J Immunol.   169 ( 9 )   4707 - 4711   2002.7

Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation Comparison of an antigenemia assay and quantitative real-time polymerase chain reaction Reviewed

K. Yakushiji, H. Gondo, Kenjiro Kamezaki, K. Shigematsu, S. Hayashi, M. Kuroiwa, S. Taniguchi, Y. Ohno, K. Takase, Akihiko Numata, K. Aoki, Koji Kato, K. Nagafuji, K. Shimoda, T. Okamura, N. Kinukawa, N. Kasuga, M. Sata, M. Harada

Bone Marrow Transplantation   29 ( 7 )   599 - 606   2002.6

Therapy-related chronic myelogenous leukaemia following autologous stem cell transplantation for Ewing's sarcoma Reviewed

Akihiko Numata, Kazuya Shimoda, Hisashi Gondo, Kouji Kato, Kenichi Aoki, Yoshikiyo Ito, Ken Takase, Yoshinobu Asano, Takashi Okamura, Yoshiyuki Niho, Mine Harada

British Journal of Haematology   117 ( 3 )   613 - 616   2002.6

Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: Comparison of an antigenemia assay and quantitative real-time polymerase chain reaction. International journal

Yakushiji K, Gondo H, Kamezaki K, Shigematsu K, Hayashi S, Kuroiwa M, Taniguchi S, Ohno Y, Takase K, Numata A, Aoki K, Kato K, Nagafuji K, Shimoda K, Okamura T, Kinukawa N, Kasuga N, Sata M, Harada M.

Bone Marrow Transplant.   2002.4

Partial impairment of interleukin-12 (IL-12) and IL-18 signaling in Tyk2-deficient mice. Reviewed International journal

Shimoda K, Tsutsui H, Aoki K, Kato K, Matsuda T, Numata A, Takase K, Yamamoto T, Nukina H, Hoshino T, Asano Y, Gondo H, Okamura T, Okamura S, Nakayama K, Nakanishi K, Niho Y, Harada M.

Blood.   99 ( 6 )   2094 - 2099   2002.2

Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation Comparison of an antigenemia assay and quantitative real-time polymerase chain reaction Reviewed

K. Yakushiji, H. Gondo, K. Kamezaki, K. Shigematsu, S. Hayashi, M. Kuroiwa, S. Taniguchi, Y. Ohno, K. Takase, A. Numata, K. Aoki, K. Kato, K. Nagafuji, K. Shimoda, T. Okamura, N. Kinukawa, N. Kasuga, M. Sata, M. Harada

Bone Marrow Transplantation   29 ( 7 )   599 - 606   2002.1

Tyk2 Plays a Restricted Role in IFN Signaling, Although It Is Required for IL-12-Mediated T Cell Function. Reviewed International journal

Shimoda K, Kato K, Aoki K, Matsuda T, Miyamoto A, Shibamori M, Yamashita M, Numata A, Takase K, Kobayashi S, Shibata S, Asano Y, Gondo H, Sekiguchi K, Nakayama K, Nakayama T, Okamura T, Okamura S, Niho Y, and Nakayama K.

Immunity   13 ( 4 )   561 - 571   2000.8

内科疾患の診断基準・病型分類・重症度 「成人T細胞性白血病」

加藤 光次（ Role： Joint author）

南江堂  2021.4 

EBM 血液疾患の治療 2021-2022　　「T/NK細胞リンパ腫（PTCL・ENKL）に対する免疫チェックポイント阻害薬」

加藤 光次, 宮脇恒太, 杉尾健志（ Role： Joint author）

中外医学社  2020.12 

悪性リンパ腫治療マニュアル 改訂第5版　　「末梢性T細胞リンパ腫」

加藤 光次（ Role： Joint author）

南江堂  2020.11 

造血器腫瘍学（第2版）―基礎と臨床の最新研究動向―　　「びまん性大細胞型B細胞リンパ腫の分類」

加藤 光次（ Role： Joint author）

日本臨牀  2020.8 

今日の治療指針 2020年版 「今日の治療指針 2020年版 -私はこう治療している 血液疾患 非ホジキンリンパ腫」

加藤 光次（ Role： Joint author）

医学書院  2020.1 

血液専門医テキスト（改訂第3版）分子標的薬の作用機序と分類

加藤 光次（ Role： Joint author）

南江堂  2019.10 

血液疾患最新の治療 2020-2022 「造血幹細胞移植: 移植にむけたブリッジング治療に伴う注意すべき合併症」

加藤 光次（ Role： Joint author）

南江堂  2019.10 

ファーマナビゲーターDIC改訂版 　造血幹細胞移植に伴う合併症に対して，抗凝固療法はどの程度期待できますか

加藤 光次（ Role： Joint author）

メディカルレビュー社  2019.10 

日本造血細胞移植学会ガイドライン　　　悪性リンパ腫（成人）第3版

伊豆津 宏二, 加藤 光次, 錦織 桃子, 賀古 真一, 金 成元, 吉田 功（ Role： Joint author）

日本造血細胞移植学会  2019.1 

EBM 血液疾患の治療 2019-2020: 再発・難治急性リンパ芽球性白血病の治療

加藤　光次（ Role： Sole author）

中外医学社  2018.11 

日本造血細胞移植学会ガイドライン　　　成人T細胞性白血病・リンパ腫（第1版）

加藤 光次, 中野 伸亮, 崔 日承, 福田 隆浩（ Role： Joint author）

日本造血細胞移植学会  2018.1 

造血細胞移植学会ガイドライン（第4巻）

加藤 光次（ Role： Edit）

医薬ジャーナル社  2017.5 

EBM 血液疾患の治療 2017-2018: 第1寛解期AMLにおける造血幹細胞移植の適応.

加藤 光次（ Role： Joint author）

中外医学社  2016.9 

血液専門医テキスト（改訂第2版）分子標的薬の作用機序と分類

加藤 光次, 宮本 敏浩（ Role： Joint author）

南江堂  2015.6 

造血細胞移植学会ガイドライン（第2巻）

加藤 光次（ Role： Edit）

医薬ジャーナル社  2014.12 

ファーマナビゲーターDIC編　造血幹細胞移植に伴う合併症に対して，抗凝固療法はどの程度期待できますか

加藤 光次（ Role： Joint author）

メディカルレビュー社  2014.11 

造血細胞移植学会ガイドライン（第3巻）

加藤 光次（ Role： Edit）

医薬ジャーナル社  2014.7 

造血細胞移植学会ガイドライン（第1巻）

加藤 光次（ Role： Edit）

医薬ジャーナル社  2014.4 

みんなに役立つGVHDの基礎と臨床：新規薬剤がGVHDに及ぼす影響

加藤 光次（ Role： Joint author）

医薬ジャーナル社  2013.8 

症例とエビデンスに学ぶ造血細胞移植と感染症: 真菌感染症 接合菌症の診断と治療

加藤光次（ Role： Joint author）

医薬ジャーナル社  2011.6 

チーム医療で行う造血幹細胞移植プラクティカルガイド：成人T細胞性白血病

加藤光次（ Role： Joint author）

南江堂  2011.1 

がん免疫療法 -実用化へのチャレンジ- : 免疫療法におけるメモリーT細胞

加藤光次（ Role： Joint author）

シーエムシー出版  2010.9 

Hematopoietic Stem Cell Transplantation Research Advances; The Evolving Role of Hematopoietic Stem Cell Transplantation in Non-Hodgkin's Lymphoma.

Kato K, Mellacheruvu S, Mineishi S.（ Role： Joint author）

Nova Publishers  2008.4 

多様化する造血幹細胞移植の適応と方法: 造血幹細胞移植発展に必要なアクセルとブレーキ.

神田善伸、秋山暢、加藤光次、鈴木律朗（ Role： Joint author）

南江堂  2006.8 

症例から学ぶ造血幹細胞移植: 成人T細胞白血病/リンパ腫に対する同種造血幹細胞移植.

加藤光次（ Role： Joint author）

中外医学社  2006.4 

必携　造血幹細胞移植: 造血幹細胞の採取、調整、移植

加藤光次（ Role： Joint author）

医学書院  2004.4 

同種移植後に発症した難治性免疫性血小板減少性紫斑病に対してfostamatinibを使用した1例

平川 聖也、迫田 哲平、宮脇 恒太、佐々木 謙介、陳之内 文昭、山内 拓司、島 隆宏、森 康雄、加藤 光次、赤司 浩一

第46回 日本造血・免疫細胞療法学会総会  2024.3 

ハイリスクAMLに対する同種造血幹細胞移植後のベネトクラクス・アザシチジン併用療法

山内 拓司、迫田 哲平、菊繁 吉謙、加藤 光次、赤司 浩一

第46回 日本造血・免疫細胞療法学会総会  2024.3 

レテルモビル予防投与がCMV以外の同種移植後ウイルス感染症発症に与える影響

森 康雄、中垣 秀隆、平川 聖也、西原 博英、山口 晃平、石原 大輔、今永 博、佐々木謙介、迫田 哲平、陳之内 文昭、仙波 雄一郎、宮脇 恒太、山内 拓司、島 隆宏、菊繁 吉謙、加藤 光次、前田 高宏、赤司 浩一

第46回 日本造血・免疫細胞療法学会総会  2024.3 

HLA半合致移植レシピエントにおけるHHV-6B脳脊髄炎の発症頻度とリスク因子

森 康雄、中垣 秀隆、平川 聖也、西原 博英、山口 晃平、石原 大輔、今永 博、佐々木謙介、迫田 哲平、陳之内 文昭、仙波 雄一郎、宮脇 恒太、山内 拓司、島 隆宏、菊繁 吉謙、加藤 光次、前田 高宏、赤司 浩一

第46回 日本造血・免疫細胞療法学会総会  2024.3 

CAR-T療法前後での身体機能および身体組成の推移

阿波村 龍一、森 康雄、藤田 努、宮里 幸、北里 直子、山田祐里奈、川口 謙一、加藤 光次

第46回 日本造血・免疫細胞療法学会総会  2024.3 

新規抗体療法時代における同種移植後再発したB細胞性急性リンパ性白血病に対する再移植成績

栗山 拓郎、久原 千愛、嶋川 卓史、南 満理子、栃木 太郎、林 正康、松尾 弥生、小川 亮介、上村 智彦、大野 裕樹、加藤 光次、衛藤 徹也、谷口 修一

第46回 日本造血・免疫細胞療法学会総会  2024.3 

再発・難治性B-ALL及びDLBCL患者におけるtisagenlecleucel規格外品の国内投与実績

加藤 光次、加藤 淳、後藤 秀樹、小林 武、高橋 義行、堺田 惠美子、岩本 章子、Ranjan Tiwari、藤井 伸治

第46回 日本造血・免疫細胞療法学会総会  2024.3 

免疫チェックポイント阻害薬投与後のCAR-T細胞療法

山口 晃平、山内 拓司、平川 聖也、中垣 秀隆、西原 博英、佐々木謙介、迫田 哲平、陳之内 文昭、宮脇 恒太、島 隆宏、森 康雄、加藤 光次、赤司 浩一

第46回 日本造血・免疫細胞療法学会総会  2024.3 

アフェレーシス前CD3リンパ球測定によるCAR-T療法の最適なリンパ球採取戦略

石原 大輔、仙波 雄一郎、山中 育未、今永 博、迫田 哲平、山内 拓司、島 隆宏、平安山 知子、加藤 光次、前田 高宏、赤司 浩一、國﨑 祐哉

第46回 日本造血・免疫細胞療法学会総会  2024.3 

同種造血幹細胞移植前の薬剤耐性菌検出が移植成績に与える影響

幸地 祐、森 康雄、山内 拓司、島 隆宏、加藤 光次、日野 賢次郎、池田 理一郎、布村 拓也、今中 亮太、牟田 毅、片山 雄太、赤司 浩一

第46回 日本造血・免疫細胞療法学会総会  2024.3 

造血幹細胞移植後再発・難治性T細胞性腫瘍 に対するBrentuximab Vedotin治療

島 隆宏、佐々木謙介、迫田 哲平、陳之内 文昭、宮脇 恒太、山内 拓司、森 康雄、加藤 光次、赤司 浩一

第46回 日本造血・免疫細胞療法学会総会  2024.3 

造血細胞移植に伴う口腔常在細菌叢の細菌構成の変化

奥 菜央理、竹下 徹、朝川美加李、塚本 葉子、今村 貴子、稲田 明美、中村 美樹子、櫻井 麻子、小松 舞、堀 公人、森 康雄、陳之内 文昭、加藤 光次、柏﨑 晴彦

第46回 日本造血・免疫細胞療法学会総会  2024.3 

同種造血細胞移植患者における口腔粘膜炎に対するクライオセラピーの効果

谷 明日香、二木 寿子、疋田 春奈、塚本 葉子、稲田 明美、中村美樹子、櫻井 麻子、小松 舞、堀 公人、山口 晃平、山内 拓司、森 康雄、加藤 光次、柏﨑 晴彦

第46回 日本造血・免疫細胞療法学会総会  2024.3 

慢性移植片対宿主病に対する施設容量の影響

下村 良充、北村 哲久、村田 誠、松尾 恵太郎、伊藤 ゆり、一戸 辰夫、橋井 佳子、後藤 秀樹、加藤 光次、石丸 文彦、佐藤 篤、鬼塚 真仁、柳澤 昌実、大引真理恵、田渕 健、熱田 由子、福田 隆浩、諫田 淳也、寺倉精太郎

第46回 日本造血・免疫細胞療法学会総会  2024.3 

ステロイド依存性/抵抗性慢性移植片対宿主病に対するベルモスジルの国内第Ⅲ相臨床試験

河北 敏郎、稲本 賢弘、加藤 光次、大西 康、松岡 賢市、白鳥 聡一、池亀 和博、平本 展大、豊﨑 誠子、片山 雄太、村山 竣、笹川 裕次、前田 嘉信、畠 清彦、豊嶋 崇徳

第46回 日本造血・免疫細胞療法学会総会  2024.3 

成人T細胞白血病・リンパ腫に対するHLA一致血縁ドナーからの同種移植における骨髄血と末梢血幹細胞の比較

糸永 英弘、福島 卓也、加藤 光次、村主 啓行、中野 伸亮、福田 隆浩、河北 敏郎、加藤 丈晴、森 康雄、森島 聡子、末廣 陽子、衛藤 徹也、澤山 靖、鬼塚 真仁、一戸 辰夫、熱田 由子、吉満 誠、藤 重夫

第46回 日本造血・免疫細胞療法学会総会  2024.3 

CAR-T細胞療法におけるICANS発症リスク因子の検討

西原 博英、陳之内 文昭、平川 聖也、中垣 秀隆、山口 晃平、石原 大輔、今永 博、山中 育未、佐々木 謙介、迫田 哲平、仙波 雄一郎、山内 拓司、宮脇 恒太、島 隆宏、森 康雄、平安山 知子、國﨑 祐哉、加藤 光次、赤司 浩一

第46回 日本造血・免疫細胞療法学会総会  2024.3 

CAR-T細胞療法における高度の好中球減少と重症感染症発症との関連

陳之内文昭、加藤 光次、山内 拓司、佐々木 謙介、迫田 哲平、宮脇 恒太、島 隆宏、森 康雄、仙波雄一郎、平安山知子、國崎 祐哉、赤司 浩一

第46回 日本造血・免疫細胞療法学会総会  2024.3 

B細胞リンパ腫治療におけるCAR-T療法の位置付け

加藤 光次

次世代がん医療を担う多職種人材養成プラン  2024.3 

DLBCL治療における今後の展望

加藤 光次

第20回ひがし血液疾患勉強会  2024.2 

ATL治療

加藤 光次

第3回 ATL治療の課題を考える会  2024.2 

造血器腫瘍治療の進歩

加藤 光次

北九州九一の会2024  2024.1 

Outcomes of Allogeneic Transplantation for Adult T-Cell Leukemia/Lymphoma in Adolescents and Young Adult (AYA) and Young Patients International conference

Hidehiro Itonaga, Takuya Fukushima, Koji Kato, Nobuaki Nakano, Takeharu Kato, Takashi Tanaka, Tetsuya Eto, Yasuo Mori, Toshiro Kawakita, Naoyuki Uchida, Yasushi Sawayama, Takahiro Fukuda, Yoshinobu Kanda, Yoshiko Atsuta, Makoto Yoshimitsu, Shigeo FujiHidehiro Itonaga, Takuya Fukushima, Koji Kato, Nobuaki Nakano, Takeharu Kato, Takashi Tanaka, Tetsuya Eto, Yasuo Mori, Toshiro Kawakita, Naoyuki Uchida, Yasushi Sawayama, Takahiro Fukuda, Yoshinobu Kanda, Yoshiko Atsuta, Makoto Yoshimitsu, Shigeo Fuji

65th American Society of Hematology Annual Meeting and Exposition  2023.12 

A Phase 1 Trial of OPB-111077 in Combination with Bendamustine (B) and Rituximab (R) in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Preliminary Results of Dose-Escalation Stage International conference

Tomomi Toubai, Junya Kuroda, Youko Suehiro, Yuko Mishima, Kazutaka Sunami, Koji Kato, Nobuhiko Uoshima, Takahiro Kumode, Ai Ota, Kaori Mitsuki, Daisuke Yokota, Yuri Sano, Yasuhito Terui

65th American Society of Hematology Annual Meeting and Exposition  2023.12 

Donor NK Cell Education By KIR3DL1 and HLA-B Associates with Reduced Relapse in Unrelated Bone Marrow Transplantation for Adult T-Cell Leukemia International conference

Mari Morita-Fujita, Takero Shindo, Shuji Kawaguchi, Kiyotaka Izumi, Yuichi Inadomi, Masakazu Shimizu, Ai Murano, Akiyo Morinibu, Meiko Takahashi, Junya Kanda, Taro Tsujimura, Takuya Yamamoto, Koji Kato, Hidenori Tanaka, Nobuaki Nakano, Tetsuya Eto, Yasuhiko Miyazaki, Kazunori Imada, MD, Youko Suehiro, Toshiro Kawakita, Tatsuo Ichinoh, Takahiro Fukuda, Makoto Onizuka, Yoshiko Atsuta, Fumihiko Matsuda, Akifumi Takaori-Kondo

65th American Society of Hematology Annual Meeting and Exposition  2023.12 

Clinical Outcomes of Patients with Relapsed/Refractory Follicular Lymphoma Treated with Tisagenlecleucel: Phase 2 Elara 3-Year Follow-up International conference

65th American Society of Hematology Annual Meeting and Exposition  2023.12 

An Integrated Multimodal Framework for Noninvasive TCL Disease Detection and Monitoring International conference

65th American Society of Hematology Annual Meeting and Exposition  2023.12 

DLBCL治療の現状と今後の展開

加藤 光次

抗体医薬 最新情報セミナー  2023.11 

PTCLの病態理解と層別化治療の可能性

加藤 光次

第2回T-cell Lymphoma Forum in 山口  2023.11 

免疫チェックポイント阻害剤を用いた悪性リンパ腫に対する新たな治療戦略

加藤 光次

2023.11 

CAR-T細胞療法の期待と課題

加藤 光次

信州 CAR-T WEB Conference 2023  2023.11 

マントル細胞リンパ腫における最新の知見

加藤 光次

第14回関西血液疾患Forum  2023.10 

造血器腫瘍に対するCAR-T細胞療法への期待と課題 Invited

加藤 光次

第30回日本輸血・細胞治療学会 秋季シンポジウム  2023.10 

免疫療法のプラットホームとしての造血幹細胞移植

加藤 光次

SOS Update Seminar in 関東甲信越 2023  2023.10 

イエスカルタ開発の歴史とUpdate

加藤 光次

イエスカルタ全国講演会  2023.10 

造血器腫瘍に対するCAR-T療法の現状と課題 Invited

加藤 光次

第61回日本癌治療学会学術集会  2023.10 

慢性骨髄単球性白血病の経過観察中にびまん性大細胞型B細胞リンパ腫を発症した一例

西原 博英，森 康雄，入船 秀俊，佐々木 謙介，迫田 哲平，陳之内 文昭，仙波 雄一郎，宮脇 恒太，山内 拓司，島 隆宏，加藤 光次，前田 高宏，赤司 浩一

第85回日本血液学会学術集会  2023.10 

Treatment patterns in patients with MCL: Updated report of the Asia-Pacific registry study

2023.10 

同種移植後のベネトクラクス・アザシチジン併用療法

山内 拓司，吉本 五一，加藤 光次，赤司 浩一

第85回日本血液学会学術集会  2023.10 

悪性リンパ腫へのtisagenlecleucelの治療効果に関するPET/CTで評価されたMTHとDmaxのインパクト

後藤 秀樹，北脇 年雄，加藤 光次，藤井 伸治，大西 康，福原 規子，山内 拓司，虎谷 和則，下茂 雅俊，小林 宏紀，小野寺 晃一，吉田 匠汰，千丈 創，小野澤 真弘，平田 健司，横田 勲，豊嶋 崇徳

第85回日本血液学会学術集会  2023.10 

成人T細胞白血病に対する非血縁者間骨髄移植後の再発とKIRアレルの相関性解析

森田 真梨，進藤 岳郎，川口 修治，清水 正和，稲富 雄一，村野 愛，森鳰 章代，諫田 淳也，高橋 めい子，辻村 太郎，山本 拓也，加藤 光次，田中 秀則，中野 伸亮，衛藤 徹也，宮崎 泰彦，今田 和典，末廣 陽子，河北 敏郎，一戸 辰夫，福田 隆浩，鬼塚 真仁，熱田 由子，松田 文彦，高折 晃史

第85回日本血液学会学術集会  2023.10 

B細胞リンパ腫に対するCD19 CAR-T細胞療法後のCMV再活性化

森 康雄，西原 博英，山口 晃平，平川 聖也，中垣 秀隆，佐々木 謙介，迫田 哲平，陳之内 文昭，宮脇 恒太，山内 拓司，島 隆宏，菊繁 吉謙，平安山 友子，國崎 祐哉，加藤 光次，赤司 浩一

第85回日本血液学会学術集会  2023.10 

シングルセル解析によるT濾胞ヘルパー細胞リンパ腫の腫瘍細胞不均一性の解明

須摩 桜子，末原 泰人，藤澤 学，安部 佳亮，坂本 竜弘, 澤 文, 坂東 裕子, 梶 大介， 杉尾 健志，加藤 光次，赤司 浩一，末永 孝生，Joaquim Carreras, 中村 直哉， 鈴木 絢子，鈴木 穣，千葉 滋，坂田 麻実子

第85回日本血液学会学術集会  2023.10 

CAEBVにおいて濾胞性ヘルパーT細胞およびB細胞関連遺伝子発現レベルはEBV陽性B細胞数と臨床予後に相関する

河本 啓介，三好 寛明，佐藤 健作，中嶋 一貴，竹内 真衣，森 匡平，宮脇 恒太，加藤 光次，高野 桂，古田 拓也，森坪 麻友子，木村 宏，大島 孝一

第85回日本血液学会学術集会  2023.10 

眼内原発悪性リンパ腫の治療成績

森 康雄，佐々木 謙介，迫田 哲平，原田 卓哉，陳之内 文昭，宮脇 恒太，山内 拓司，島 隆宏，加藤 光次，前田 高宏，赤司 浩一

第85回日本血液学会学術集会  2023.10 

DLBCLの早期の孤発性中枢神経再発症例に対してCAR T細胞療法が有効かつ安全に施行した一症例

瀧川 健，河野 徳明，栃木 太郎，仲池 隆史，丸塚 浩助，山下 清，森 康雄，加藤 光次，赤司 浩一

第85回日本血液学会学術集会  2023.10 

Current Status and Challenges of CAR-T Therapy for Hematological Malignancies in Japan Invited International conference

Koji Kato

The 7th Congress of International Congress of BMT 2023  2023.8 

PTCL治療 Invited

加藤 光次

第2回抗癌剤治療の副作用マネジメントとチーム医療  2023.7 

PTCL治療における期待と課題

加藤 光次

2023.7 

造血器腫瘍に対するCAR-T治療 Invited

加藤 光次

第8回日本脳腫瘍学会 (Webinar講演会)  2023.6 

The genetic subtypes and the tumor microenvironment signatures are associated with distinct outcomes in peripheral T-cell lymphoma

2023.6 

濾胞性リンパ腫に対する新規治療の考え方 Invited

加藤 光次

第63回日本リンパ網内系学会学術集会・総会　コーポレートセミナー  2023.6 

Phase 1 KEYNOTE-A33 : pembrolizumab in Japanese patients with relapsed or refractory primary mediastinal large B-cell Lymphoma (PMBCL)

Koji Izutsu, Sosuke Nakamura, Akira Wakana, Yasuhiro Koh, Koji Kato

2023.6 

造血器腫瘍における診断と治療の進歩 Invited

加藤 光次

第64回日本臨床細胞学会総会春期大会 コーポレートセミナー  2023.6 

キムリアにおける治療戦略及び治療施設と紹介元施設の連携について Invited

加藤 光次

2023.5 

Recent advances in CAR-T therapy Invited

2023.5 

DLBCL治療update Invited

加藤 光次

第31回 宮崎造血因子研究会  2023.5 

PTCLの層別化治療の可能性 Invited

加藤 光次

2023.4 

日韓両国から学ぶより良いCAR-T細胞療法の実現に向けて Invited

加藤 光次

2023.4 

Clinical trialから考察する、分子標的治療のこれから ～CLL、MCL、WM/LPL～ Invited

加藤 光次

2023.4 

DLBCL治療：大きく変わる治療の景色 Invited

加藤 光次

リンパ腫三昧  2023.3 

ATLの治療 Invited

加藤 光次

造血器腫瘍Webセミナー  2023.3 

悪性リンパ腫における微小環境の空間解析 Invited

加藤 光次

NanoString 空間生物学サミット 2023  2023.3 

CAR-T療法開発への期待と課題：造血器腫瘍から固形腫瘍への展開 Invited

加藤 光次

第20回日本臨床腫瘍学会学術集会  2023.3 

DLBCL治療 Update：大きく変わる治療の景色 Invited

加藤 光次

2023.3 

DLBCL治療 update ‐新しい治療の景色‐ Invited

加藤 光次

福島血液疾患Webセミナー  2023.3 

CAR-T療法 Invited

加藤 光次

輸血・細胞治療セミナー  2023.2 

移植非適応ATLに対する治療戦略 Invited

加藤 光次

第2回 ATL治療の課題を考える会  2023.2 

急性リンパ性白血病に対する細胞療法の展開 Invited

加藤 光次

第45回日本造血細胞移植学会総会　コーポレートセミナー  2023.2 

PTCLにおける Precision Medicine Invited

加藤 光次

第45回日本造血細胞移植学会総会　コーポレートセミナー  2023.2 

小児再発・難治 B 細胞性急性リンパ芽球性白血病に対する治療戦略、移植かCAR-T か -自施設の経験-

古賀 友紀、加藤 稚子、小野 宏彰、横山 智美、熊谷 拓哉、加藤 光次、 平安山 知子、前田 高宏、水野 晋一、赤司 浩一、大賀 正一

第45回 日本造血・免疫細胞療法学会総会  2023.2 

造血細胞移植症例におけるSARS-CoV-2ワクチンbooster接種の有効性: 多施設共同前向き観察研究

森 康雄、長藤 宏司、内田 直之、和氣 敦、片山 雄太、岩崎 浩己、衛藤 徹也、藤崎 智明、伊藤 能清、上村 智彦、高橋 勉、今村 豊 、 谷本 一史、石塚 賢治、杉田 純一、河野 徳明、谷本 一樹、吉本 五一、崔 日承、日高 智徳、小川 亮介、高松 泰、加藤 光次、宮本 敏浩、赤司 浩一

第45回 日本造血・免疫細胞療法学会総会  2023.2 

再発又は難治性の大細胞型 B 細胞リンパ腫日本人患者における Axi-Cel 第 II 相試験 : 2年追跡データ

諫田 淳也、加藤 光次、蒔田 真一、後藤 秀樹、藤井 伸治、島田 和之、 赤司 浩一、伊豆津 宏二、豊嶋 崇徳、福田 奈津子、炭谷 徳人、角 紘幸、 稲葉 真一、加倉井 靖之、吉川 謙次、飛内 賢正、薄井 紀子、畠 清彦

第45回 日本造血・免疫細胞療法学会総会  2023.2 

同種造血細胞移植前後での客観的運動耐容能と自覚的疲労感の変化は乖離する: 退院時点の短期的比較検討

阿波村 龍一、森 康雄、藤田 努、宮里 幸、北里 直子、御厨 咲江、 池田 翔 、稲田 明美、中村 美樹子、勝部 はる奈、川口 謙一、加藤 光次

第45回 日本造血・免疫細胞療法学会総会  2023.2 

Pro・Con DLBCL: CAR-Tとauto HSCTの位置付け Invited

加藤 光次、伊豆津 宏二

第45回 日本造血・免疫細胞療法学会総会  2023.2 

DLBCL治療Update‐変わる治療の風景‐ Invited

加藤 光次

2023.1 

ATLに対する治療戦略 Invited

加藤 光次

再発・難治性PTCL＆ATLの治療戦略  2023.1 

YTB323 (Rapcabtagene Autoleucel) Demonstrates Durable Efficacy and a Manageable Safety Profile in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Phase I Study Update International conference

Pere Barba, Mi Kwon, Javier Briones, Ulrich Jaeger, Emmanuel Bachy, Didier Blaise, Nicolas Boissel, Koji Kato, Nirav N. Shah, Matthew Frigault, Peter A. Riedell, Leyla O. Shune, Takanori Teshima, Fabio Ciceri, David Pearson, Elena J Orlando, Lan Yi, Jaclyn Davis, Aisha Masood, Ian W. Flinn, Michael Dickinson

64th American Society of Hematology Annual Meeting and Exposition  2022.12 

Long-Term Clinical Outcomes and Correlative Efficacy Analyses in Patients (Pts) with Relapsed/Refractory Follicular Lymphoma (r/r FL) Treated with Tisagenlecleucel in the Elara Trial International conference

64th American Society of Hematology Annual Meeting and Exposition  2022.12 

Indirectly Recognizable Epitopes Derived from Recipient Mismatched HLA-B Are Associated with Adverse Prognosis in Single-Unit Cord Blood Transplantation International conference

Takeshi Sugio, Koji Kato, Naoyuki Uchida, Kohta Miyawaki, Matthias Niemann, Eric Spierings, Makoto Onizuka, Yasufumi Uehara, Masatsugu Tanaka, Noriko Doki, Tetsuya Eto, Hikaru Kobayashi, Yumiko Maruyama, Tatsuo Ichinohe, Junya Kanda, Yoshiko Atsuta, Satoko Morishima

64th American Society of Hematology Annual Meeting and Exposition  2022.12 

DLBCL治療Update Invited

加藤 光次

第21回筑後ヘマトロジーセミナー  2022.12 

How to properly deliver Pola+R-CHP regimen to previously untreated DLBCL patients Invited

CHUGAI Lymphoma Symposium 2022  2022.11 

DLBCL治療Update Invited

加藤 光次

悪性リンパ腫最新情報セミナー  2022.10 

DLBCL治療Update Invited

加藤 光次

2022.10 

CHOP followed by mogamulizumab for untreated elderly patients with adult T-cell leukemia-lymphoma

2022.10 

HLA-B supertype mismatch is associated with a higher rate of relapse in cord blood transplantation (Plenary session) .

2022.10 

Magic bullet （魔法の弾丸): 血液疾患における開発の道のりとこれから Invited

加藤 光次

第17回血液内科研修医セミナー in 愛媛  2022.8 

DLBCL治療Update Invited

加藤 光次

2022.8 

CAR-T療法への期待と課題 Invited

加藤 光次

第27回沖縄SCT懇話会  2022.6 

CAR-T療法で変わるDLBCL治療の景色 Invited

加藤 光次

第2回血液学の夕べ in Kyoto  2022.6 

造血器腫瘍治療における細胞療法への期待と課題 Invited

加藤 光次

佐賀血液疾患フォーラム  2022.5 

CAR-T治療の現在地と未来 Invited

加藤 光次

CAR-T全国Web講演会  2022.5 

大きく変わるDLBCL治療 Invited

加藤 光次

第44回日本造血細胞移植学会総会  2022.5 

CAR-T療法における今後の期待と課題 Invited

加藤 光次

第44回日本造血細胞移植学会総会  2022.5 

DLBCL治療 Update Invited

加藤 光次

2022.4 

FL治療: ますます広がる治療の選択肢 Invited

加藤 光次

第3回北陸血液免疫懇話会  2022.3 

CAR-T細胞療法 Invited

加藤 光次

第49回日本集中治療医学会学術集会  2022.3 

DLBCL治療 Update 変わる治療の風景 Invited

加藤 光次

免疫グロブリンセミナー in 北陸  2022.3 

悪性リンパ腫における細胞療法の展望 Invited

加藤 光次

第30回長崎幹細胞移植研究会  2022.2 

PTCL治療における今後の展望 Invited

加藤 光次

ハイヤスタ錠発売記念講演会  2022.2 

ATL治療における今後の展望 Invited

加藤 光次

リンパ腫Webセミナー in 富山  2022.1 

DLBCL治療 Update 大きく変わりつつある治療の景色 Invited

加藤 光次

2022.1 

CHOP Plus Sequential Mogamulizumab As First-Line Therapy for Untreated Adult T-Cell Leukemia-Lymphoma International conference

Tanimoto K, Kato K, Aoki T, Yoshimoto G, Choi I, Kadowaki M, Sugio Y, Kuriyama T, Kawano N, , Suzuki R, Miyawaki K, Henzan H, Saito N, Ohta T, Miyamoto T, Akashi K.

63rd American Society of Hematology Annual Meeting and Exposition  2021.12 

Efficacy of Tisagenlecleucel in Adult Patients (Pts) with High-Risk Relapsed/Refractory Follicular Lymphoma (r/r FL): Subgroup Analysis of the Phase II Elara Study International conference

63rd American Society of Hematology Annual Meeting and Exposition  2021.12 

造血器腫瘍治療の進歩 Invited

加藤 光次

2021.11 

移植非適応ATLの治療戦略 Invited

加藤 光次

ATL治療の課題を考える会  2021.11 

造血器腫瘍に対する治療の最前線 Invited

加藤 光次

第5回日本検査血液学会　九州支部学術集会  2021.11 

造血器腫瘍に対するCAR-T細胞療法の現状と今後 Invited

加藤 光次

第42回日本アフェレシス学会学術大会  2021.10 

遺伝子細胞療法の展望 Invited

加藤 光次

2021.10 

濾胞性リンパ腫の治療ストラテジー Invited

加藤 光次

2021.10 

造血器腫瘍に対するCAR-T細胞療法への期待と課題 Invited

加藤 光次

第28回 日本輸血・細胞治療学会 秋季シンポジウム  2021.10 

DLBCL治療 Update: 大きく変わりつつある治療の景色 Invited

加藤 光次

第2回 Keio Hematplogy Aliance研究会  2021.10 

CAR-T療法への期待と課題 Invited

加藤 光次

第59回愛媛臨床血液懇話会  2021.10 

Clinical Debate 悪性リンパ腫

加藤 光次、棟方 理、櫻井 政寿

第83回日本血液学会学術集会  2021.9 

変わりつつあるDLBCL治療 Invited

加藤 光次

第83回日本血液学会学術集会  2021.9 

再発又は難治性の大細胞型 B 細胞リンパ腫日本人患者におけるAxi-Cel への耐性メカニズム

加藤 光次

第83回日本血液学会学術集会  2021.9 

DLBCL治療 Update Invited

加藤 光次

2021.9 

DLBCL治療 Update Invited

加藤 光次

2021.8 

BTKi の投与マネジメント Invited

加藤 光次

2021.8 

DLBCL治療 Update Invited

加藤 光次

悪性リンパ腫最新情報セミナー  2021.7 

DLBCL治療 Update Invited

加藤 光次

2021.6 

DLBCL治療 Update Invited

加藤 光次

2021.6 

CAR-T細胞療法の現状と今後 Invited

加藤 光次

2021.6 

DLBCL治療 Update Invited

加藤 光次

DLBCL最新情報WEBセミナー  2021.6 

CAR-T療法の新展開 Invited

加藤 光次

第17回京浜血液懇話会  2021.5 

びまん性大細胞型B細胞リンパ腫の50年 層別化治療はどこまですすんだか？ Invited

加藤 光次

2021.5 

Infusion-related reactions Invited

CHUGAI Lymphoma Symposium 2021  2021.5 

びまん性大細胞型B細胞リンパ腫 (DLBCL)　最近の治療の進歩 Invited

加藤 光次

北九州リンパ腫セミナー  2021.4 

遺伝子細胞療法の現状と今後 Invited

加藤 光次

第22回熊本血液コロキウム  2021.3 

悪性リンパ腫における免疫療法の展開 Invited

加藤 光次

2021.3 

CAR-T療法の展開 Invited

加藤 光次

第43回日本造血幹細胞移植学会総会  2021.3 

AMLに対するuBMT後に発症したドナー由来のBurkitt lymphomaに対しpseudo-autologous HSCTを施行した一例

内海 紗江、幸地 祐、田矢 祐規、谷口 志保、森 康雄、仙波　雄一郎、宮脇 恒太、島 隆宏、吉本 五一、沼田 晃彦、加藤 光次、前田 高宏、内田 直之、宮本 敏浩、谷口 修一、赤司 浩一

第43回日本造血細胞移植学会総会  2021.3 

FLT3阻害薬により同種造血幹細胞移植に橋渡しできたt(6;9)(p23;q34)を伴う急性骨髄性白血病の一例

幸地 祐、光山 由祐、渡部 遥、米川 晶子、江里口　芳裕、森 康雄、籾井 健太、島 隆宏、吉本 五一、沼田 晃彦、加藤 光次、宮本 敏浩、前田 高宏、赤司 浩一

第43回日本造血細胞移植学会総会  2021.3